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Autonomic Reactivity and Recovery in Healthy Black, White, and Hispanic Women 
With and Without a Family History of Cardiovascular Disease 
 Mardís Karlsdóttir 
Abstract 
 Exaggerated cardiovascular reactivity and impaired recovery to psychological 
stress is independently related to cardiovascular disease (CVD), and may play a causal 
role in its development. I examined autonomic reactivity and recovery in 136 black, 
white, and Hispanic women who were predisposed to CVD, as indicated by a positive 
family history (FH+). Pre-ejection period (PEP; sympathetic) and respiratory sinus 
arrhythmia (RSA; parasympathetic) were measured during public speaking, mental 
arithmetic, and cold pressor tasks. Overall, FH+ participants exhibited greater RSA 
reactivity, while black participants exhibited impaired RSA recovery. These findings 
suggest that a hereditary predisposition for CVD is related to altered autonomic reactivity 
before any differences in resting levels are observed. Further, black participants did not 
exhibit a RSA rebound after the stress tasks, a key component in buffering the damaging 
effects of exaggerated sympathetic reactivity. These findings demonstrate the importance 
of examining parasympathetic activity in addition to sympathetic reactivity measures. 
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Background 
Cardiovascular disease (CVD) is currently the leading cause of death among 
Americans (American Heart Association, 2007). While many risk factors for CVD have 
been identified, their role in the etiology of CVD is not fully understood. One such risk 
factor is heredity, and encompasses both a family history of CVD as well as ethnicity. It 
has been suggested that cardiovascular reactivity (i.e. changes in cardiovascular activity 
in response to an acute stressor) and recovery (i.e. the time it takes for cardiovascular 
reactivity to return to baseline following an acute stressor) may play a role in the 
development of CVD. The research on reactivity and recovery has primarily focused on 
sympathetic activation in predicting CVD. However, in recent years the protective effects 
of the parasympathetic nervous system have received more attention. The purpose of the 
present study is to investigate the effects of ethnicity and family history of CVD on 
parasympathetic reactivity in healthy women. 
Cardiovascular Disease 
Rates. The American Heart Association (2007) estimates that nearly one in three 
(i.e., 80 million) American adults have at least one form of CVD. Total CVD includes 
high blood pressure (hypertension), coronary heart disease, heart failure, and stroke. 
CVD accounts for 36.3% of all deaths in the United States, and has been the number one 
cause of death among Americans every year since 1919 (American Heart Association, 
2007). Furthermore, CVD is the cause of 48% of all deaths in Europe (European Heart 
Network, 2008). 
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Risk Factors. The American Heart Association (2007) has classified risk factors 
for cardiovascular disease into major risk factors and contributing risk factors. Major risk 
factors significantly increase the likelihood of developing CVD, while contributing 
factors are factors whose significance or prevalence have not been established as strongly 
as major risk factors. There are three major risk factors for CVD that cannot be changed: 
age, sex, and heredity. The heredity risk factor encompasses both a positive family 
history of heart disease and ethnicity. In addition, there are three major physical risk 
factors for cardiovascular disease that can be altered or controlled, including high 
cholesterol, high blood pressure, and Type II diabetes. The risk for cardiovascular disease 
increases as age increases. Males have higher rates of cardiovascular disease than women 
until women reach menopause, at which point there is a higher prevalence in women than 
men (American Heart Association, 2007).  
Reactivity Hypothesis – The Link between Stress and CVD? 
Physiological responses to stress. Although there is disagreement on how 
underlying physiological mechanisms may cause CVD, there is a consensus that 
pathological behaviors occur in certain elements within the autonomic cardiovascular 
control system. Autonomic control of the cardiovascular system may become 
dysregulated, leading to early cardiovascular pathology. This dysregulation is one 
hypothesized pathway explaining the relationship between psychosocial factors and CVD 
development. Before discussing further the literature regarding psychosocial risk factors 
and dysregulation of autonomic cardiovascular control, it is necessary to present an 
overview of the autonomic nervous and cardiovascular systems. 
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The autonomic nervous system is comprised of the sympathetic nervous system 
and the parasympathetic nervous system. The sympathetic nervous system, or “fight or 
flight” system, is active during physical or psychological stress, increasing physiological 
arousal (e.g. blood pressure and heart rate) to facilitate coping and adaptation to the 
stressor. In contrast, the parasympathetic nervous system, or “rest and digest” system, is 
most active during safety and stability where it decreases physiological arousal (e.g. heart 
rate). It is adaptive for a person to have the ability to transition quickly between high and 
low arousal states (Appelhans & Luecken, 2006). 
As early as the 1930’s, researchers have pointed to a possible link between 
autonomic responsivity to stress and vulnerability to disease (Barnett, Hines, Schirger, & 
Gage, 1963; McEwen, 1998; Selye, 1937; Selye, 1938; Selye, 1965). For example, Hines 
and Brown (1932) first reported that a large increase in blood pressure during a cold 
pressor task, which consists of either placing a bag of ice on the forehead or submerging 
the forearm into ice water, was indicative of future hypertension (as cited in Lovallo, 
2005). After a series of experiments demonstrated that a prolonged stressor could lead to 
disease, illness, and death, Selye developed his theory of the general adaption syndrome 
which consists of three stages in response to a stressor: alarm, resistance, and exhaustion 
(Selye, 1965). Alarm and resistance follow a stressor, and if the stressor is prolonged, 
exhaustion may set in. Although the body’s physiological systems work adaptively to 
respond to a stressor, if these responses are prolonged they become maladaptive. After 
Selye’s general adaptation syndrome introduced the concept of stress-induced 
sympathetic hyperactivity, interest in relating the syndrome to specific diseases grew 
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quickly. Selye’s theory has been linked to several cardiovascular diseases, including heart 
disease, atherosclerosis, hypertension, and diabetes (Hellstrom, 2007; McEwen, 1998).  
Reactivity. One model that has directed much of the research on stress in general 
is the reactivity hypothesis (Krantz & Manuck, 1984). The original reactivity hypothesis 
proposed that an exaggerated blood pressure response to a psychological stressor is a risk 
marker of future CVD (Fredrikson & Matthews, 1990; Manuck, Kasprowicz, & 
Muldoon, 1990). The hypothesis was developed after several studies demonstrated that 
young participants with normal blood pressure, but at risk for future development of 
hypertension, had an exaggerated blood pressure response to a variety of laboratory 
challenges (Fredrikson & Matthews, 1990; Manuck, Kasprowicz, & Muldoon, 1990). 
The reactivity hypothesis drew more attention as increasing evidence showed a 
connection between the Type A behavior pattern, hostility and exaggerated reactivity to 
stress (Myrtek & Greenlee, 1984). Since it was originally proposed, the reactivity 
hypothesis has been expanded to include the reactivity of other cardiovascular measures, 
such as heart rate. 
Reactivity typically refers to a change in cardiovascular functioning from baseline 
in response to an aversive or challenging psychological task that takes place in a 
laboratory (Kamarck & Lovallo, 2003). A number of physiological changes can be 
observed during an acute psychological stressor, such as elevated heart rate, systolic 
blood pressure (SBP), epinephrine and norepinephrine levels, and adrenocorticotropic 
hormone levels (McCann et al., 1995; Pike et al., 1997; Treiber et al., 1993). There are 
several tasks that are prominent in the cardiovascular reactivity and disease risk literature. 
These include mental arithmetic (Matthews, Woodall, & Allen, 1993; Sharpley et al., 
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2000), a cold pressor task (Kasagi, Akahoshi, & Shimaoka, 1995; Roy-Gagnon et al., 
2008), mirror star tracing (Matthews, Salomon, Brady, & Allen, 2003; Salomon, 2005), 
and a public speech task (Salomon, Clift, Karlsdóttir, & Rottenberg, 2009). In general, 
cardiovascular reactivity is considered a trait characteristic, and is believed to indicate 
how an individual typically responds to daily stressors (Kamarck & Lovallo, 2003). 
Lovallo (2005) stated that individual differences in reactivity may be due to structural 
and functional variations in the cardiovascular and endocrine systems, signaling either 
susceptibility to disease or pathology. On the other hand, Salomon (2005) suggests that 
individual differences in reactivity reflects the interaction of biological, personality, and 
social factors within a person that leads to stable response tendencies. 
According to the reactivity hypothesis, exaggerated responses to acute stress can 
result in pathophysiologic events, which can cause tissue damage that results in system 
dysregulation, which then leads to disease (Obrist, Light, James, & Strogatz, 1987). 
Previous studies have found that exaggerated cardiovascular reactivity to a laboratory 
stressor is an independent risk factor for CVD (Treiber et al., 2003). These include 
carotid artery disease (Barnett, Spence, Manuck, & Jennings, 1997), hypertension, 
coronary heart disease, increased left plaque rupture, thrombus formation, and the 
development of carotid atherosclerosis (Manuck, 1994; Treiber et al., 2003). One study 
found that SBP reactivity to a cold pressor task predicted hypertension 20-36 years later, 
even after adjusting for study entry age, body mass index (BMI), smoking, family history 
of hypertension, and pretest SBP (Menkes et al., 1989). Similarly, Everson and 
colleagues (1996) found that SBP reactivity to an exercise stress task predicted high 
blood pressure four years later, which was still significant after adjusting for relevant 
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factors. Furthermore, exaggerated cardiovascular reactivity has predicted the 
development of hypertension up to 45 years later (see Treiber et al., 2003 for a review).  
Despite the accumulated evidence, some studies have found that reactivity does 
not predict hypertension (Carroll et al., 2001). As a result of the inconsistencies in the 
literature, it has been recommended that reactivity not be considered a unitary construct, 
as blood pressure responses are not determined by one underlying mechanism 
(Kasprowicz, Manuck, Malkoff, & Krantz, 1990). In addition, the underlying 
mechanism’s role in the etiology of CVD may differ (Manuck et al., 1990; Tomaka, 
Blascovich, Kelsey, & Leitten, 1993). For example, blood pressure can fluctuate as a 
result of cardiac change (e.g. heart rate, cardiac output), or vascular change (e.g. 
peripheral resistance). Some researchers have argued that vascular reactivity is 
maladaptive, while cardiac reactivity might indicate behavioral flexibility and effective 
coping (Dienstbier, 1989; Lovallo, 2005). However, findings in this area have been 
inconsistent. For example, one study found that cardiac reactivity as opposed to vascular 
reactivity predicted higher blood pressure in adolescents at a three-year follow up 
(Matthews et al., 2003). In addition, Manuck, Kaplan, and Clarkson (1983) found that 
heart rate reactivity was positively related to the development of atherosclerosis in 
cynomolgus monkeys. 
Although there is a debate among researchers as to the clinical significance of 
cardiovascular reactivity (Linden, Gerin, & Davidson, 2003; Manuck, 1994), the question 
remains as to whether exaggerated reactivity plays a causal role in the development of 
CVD or if it is only an indication of future risk. In a recent review, Treiber and 
colleagues (2003) concluded that there was sufficient evidence for the predictive power 
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of cardiovascular reactivity on the etiology of CVD and its outcomes (Treiber et al., 
2003). 
Recovery. While cardiovascular reactivity provides important insights into 
cardiovascular disease, the reactivity hypothesis does not paint a complete picture. A 
major criticism of the reactivity hypothesis is that it does not address the duration of 
stress, chronic stress, or prolonged activation after stress (Schwartz et al., 2003). The 
failure of the cardiovascular system to recover after a stressor has received increased 
attention recently and is emerging as another important risk factor for CVD (Schwartz et 
al., 2003). Christenfeld, Glynn, and Gerin (2000) proposed that the duration for recovery 
and the magnitude of reactivity might have equally important roles in the development 
cardiovascular disease. Researchers typically measure recovery in one of three ways: (1) 
the amount of time it takes the cardiovascular system to return to baseline; (2) the 
average elevation during a post-task period; or (3) calculating the difference between 
baseline levels and elevation at a fixed time after the stressor (Christenfeld et al., 2000). 
However, these measures have been found to have low reliability and are unable to 
capture the process of recovery as a whole. Christenfeld, Glynn, and Gerin (2000) 
suggest using curve-fitting approaches instead, where both speed and amount of recovery 
can be assessed.  
In a sample of patients with chest pain, prolonged heart rate recovery in response 
to a treadmill exercise test was an independent predictor of vascular dysfunction, which 
contributes to the development of atherosclerosis (Huang et al., 2004). Impaired heart 
rate recovery also predicts coronary events (Pitsavos et al., 2004), hypertension, and even 
mortality (Cole, Foody, Blackstone, & Lauer, 2000). Further, impaired blood pressure 
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recovery has been linked to acute myocardial infarction (Laukkanen et al., 2004; 
Laukkanen et al., 2006), carotid atherosclerosis and low socioeconomic status, a risk 
factor for CVD (Steptoe, Donald, O'Donnell, Marmot, & Deanfield, 2006). One 
longitudinal study using borderline hypertensives reported that everyone who developed 
hypertension five years later failed to reach baseline diastolic blood pressure (DBP) 
levels during a five-minute recovery period, compared to 21% of those who did not 
develop hypertension (Borghi, Costa, Boschi, Mussi, & Ambrosioni, 1986). Impaired 
SBP recovery in adolescents with a family history of CVD was predictive of higher SBP 
levels four years later (Treiber et al., 2001). In an adult sample, Singh and colleagues 
(1999) found that delayed SBP recovery to an exercise test predicted the onset of 
hypertension eight years later in men. Similarly, Stewart, Janicki, and Kamarck (2006) 
reported that SBP recovery predicted SBP and DBP at a three-year follow-up, even after 
traditional blood pressure predictors were accounted for. In this study, reactivity 
measures were not related to future blood pressure, suggesting that some predictive 
information is unique to cardiovascular recovery. There is also a relationship between 
delayed cardiovascular recovery and other variables known to play a role in 
cardiovascular disease, such as hostility (Neumann, Waldstein, Sollers, Thayer, & Sorkin, 
2004), anxiety (see Brosschot, Gerin, & Thayer, 2006 for review), stressful life events, 
and physical fitness (see Hocking Schuler & O’Brien, 1997 for a review).  
Heart Rate Variability 
Just as inconsistencies in the reactivity hypothesis literature led researchers to 
consider the underlying hemodynamic influences on blood pressure reactivity, 
researchers are now expanding their view of reactivity to include contributions from the 
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parasympathetic nervous system. Historically, studies using the reactivity hypothesis 
framework have focused solely on reactivity measures mediated by the sympathetic 
nervous system, and largely ignored the parasympathetic nervous system. The 
assumption was that there was a reciprocal relationship between the sympathetic and 
parasympathetic nervous systems, so that if activity in one increased, activity in the other 
would decrease. However, it is now accepted that the sympathetic and parasympathetic 
branches of the autonomic nervous system can interact in a variety of ways beyond just 
producing antagonistic effects (i.e. a coupled reciprocal mode of activity). These include 
coupled nonreciprocal modes where both systems increase or decrease, or uncoupled 
modes where activity in one system is uncorrelated to activity in the other system 
(Bernston, Cacioppo, & Quigley, 1991).  
One way to assess parasympathetic activity is by measuring heart rate variability 
(HRV), or changes in heart rate on a beat-to-beat basis. The vagus nerve, located on the 
tenth cranial nerve, regulates the parasympathetic activity of the heart. In the 
cardiovascular literature, the term vagal is often used interchangeably with 
parasympathetic. The sympathetic and parasympathetic branches of the autonomic 
nervous system regulate heart rate by altering the activity of the sinoatrial node. The 
sinoatrial node consists of cells located in the right atrium of the heart that generate 
impulses that trigger cardiac contraction. When the sympathetic fibers are stimulated, 
they have an excitatory effect on the firing rate of the sinoatrial node, causing an 
increased heart rate and a decreased inter-beat interval (the time in milliseconds between 
sequential heart beats). The opposite occurs when the vagus nerve is stimulated, and heart 
rate decreases and inter-beat interval increases. Thus, heart rate can decrease through 
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either sympathetic inhibition or parasympathetic activation (Appelhans & Luecken, 
2006).  
HRV is often apparent in the respiratory cycle, where inspiration blocks 
parasympathetic influence and heart rate accelerates, while exhalation restores 
parasympathetic influence and heart rate decelerates. This phenomenon is referred to as 
respiratory sinus arrhythmia (RSA), and is considered by most researchers to be a fairly 
direct measure of parasympathetic influence on the heart. High RSA, or high vagal tone, 
occurs when there is a large amount of variability coincident with the respiratory cycle. 
Likewise, low RSA, or poor vagal tone, describes little or no variability in heart rate 
during respiration. Cardiac vagal tone has been established as a reliable individual trait 
(Cacioppo, Uchino, & Berntson, 1994).  
HRV is measured through continuous recording of heart rate using ECG, and then 
calculating inter-beat interval fluctuations (Task Force, 1996). Additionally, HRV occurs 
at different frequencies. These frequencies are due to the unique temporal characteristics 
of sympathetic and parasympathetic influences on the heart. Sympathetic influences on 
heart rate rely on norepinephrine neurotransmission, and take longer to affect changes in 
heart rate. On the other hand, parasympathetic influences on heart rate involve 
acetylcholine neurotransmission, which produces relatively quick changes in heart rate 
(Pumprla, Howorka, Groves, Chester, & Nolan, 2002). These frequency differences can 
be examined using power spectral analysis of HRV, which typically divides inter-beat 
interval variation into a spectrum of frequencies using the fast Fourier transform. The 
frequencies are categorized into very low frequency (VLF) power, low frequency (LF) 
power, and high frequency (HF) power. LF power may indicate mainly sympathetic or a 
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combined sympathetic and parasympathetic influence, while HF power reflects 
parasympathetic influence caused by RSA. Since it is not certain whether LF includes 
parasympathetic activity, the ratio of LF to HF power is often reported, illustrating the 
balance between, or predominance of, the sympathetic and parasympathetic nervous 
systems (Task Force, 1996).  
Evidence for Importance of HRV 
Resting levels linked to disease. HRV is related to various other physiological 
processes such as arrhythmic events (Huikuri et al., 1993), cognitive impairment (Kim et 
al., 2006), subclinical inflammation (Sajadieha et al., 2004), and aging (Stratton et al., 
2003). Furthermore, reduced HRV is linked to a number of diseases of the cardiovascular 
system, including hypertension (Huikuri et al., 1996), diabetes mellitus (Carnethon, 
Golden, Folsom, Haskell, & Liao, 2003; Lindmark, Wiklund, Bjerle, & Eriksson, 2003), 
and congestive heart failure (Boveda et al., 2001). Low HRV has also been linked to 
psychosocial factors related to the development of CVD, such as depression (O'Connor, 
Allen, & Kaszniak, 2005; Rottenberg et al., 2007), anxiety (Fuller, 1992), hostility 
(Demaree & Everhart, 2004), and neuroticism (Haug et al., 1994).  
A large amount of evidence is available on the relationship between low HRV and 
higher mortality. Using a population-based sample, Dekker and colleagues (2000) 
examined HRV in relation to mortality. Results showed that in initially healthy subjects, 
those with the lowest RSA levels had the highest risk of coronary heart disease and death. 
Another population-based study using elderly participants reported that LF, HF, and total 
power HRV at baseline were related to all-cause mortality five years later (Tsuji et al., 
1994). Additionally, Tsuji and colleagues (1996) reported that LF, HF, and total power 
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HRV were associated with increased risk for cardiac events, even after adjusting for 
clinical risk factors. Similar findings have also been reported using clinical populations, 
such as congestive heart failure patients (Nolan et al., 1998) and in patients with recent 
myocardial infarction (La Rovere, Bigger, Marchus, Mortara, & Schwartz, 1998).  
Hayano and colleagues (1990) reported that RSA was reduced as the severity of 
atherosclerosis increased, and that this association remained significant after adjusting for 
age, sex, and previous myocardial infarction. Wennerblom and colleagues (2000) 
reported that in a sample of patients with uncomplicated coronary artery disease without 
previous myocardial infarction, total, LF and HF HRV were reduced, as compared to 
healthy controls. Using a patient sample, Huikuri and colleagues (1999) found that 
reduced total HRV predicted the progression of atherosclerosis, with those with the 
lowest total HRV had progressed coronary artery disease and those with the highest total 
HRV showing regressed coronary artery disease. Further, this association remained 
significant after adjusting for the severity of ischemic heart disease as well as common 
risk factors. This suggests that HRV is independently related to the progression of 
atherosclerosis, as opposed to being the result of severe ischemic heart disease. 
Studies have indicated that reduced parasympathetic activity is apparent in 
hypertension. Singh and colleagues (1998) found that hypertensives displayed increased 
LF power and decreased RSA when compared to normotensives (i.e., those with normal 
blood pressure). Furthermore, normotensive males with high LF power at baseline were 
more likely to develop hypertension at a four-year follow up (Singh et al., 1998). Using a 
population-based sample, Liao et al. (1996) found that over a three year follow-up, there 
was an inverse relationship between RSA and incident hypertension.   
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Additionally, patients have shown a decrease in RSA following a stroke, 
compared to controls (Dutsch, Burger, Dorfler, Schwab, & Hilz, 2007). After a right-
sided stroke, LF/HF ratio is elevated compared to patients with a left-sided stroke and 
controls (Dutsch et al., 2007), suggesting an increase in sympathetic and a decrease in 
parasympathetic activity. Furthermore, a relationship is seen between HRV and the 
degree of neurological deficits and functional abilities in stroke patients. Specifically, 
individuals who were rated as functionally dependent had decreased LF and HF HRV 
(Arad, Abboud, Radai, & Adunsky, 2002). 
Additionally, resting levels of HRV and RSA are related to diabetes, a disease 
that is closely related to CVD morbidity and mortality. HRV can be used to assess 
cardiac autonomic neuropathy (CAN), a condition that occurs when the autonomic nerve 
fibers that innervate the heart and blood vessels have been damaged (Maser, Mitchell, 
Vinik, & Freeman, 2003). CAN changes the regulation of blood pressure, heart rate, and 
HRV, and is related to sudden cardiac death and susceptibility to ventricular arrhythmias 
(Gerritsen et al., 2001). CAN has a high prevalence rate in Type I and Type II diabetes, 
and can be seen during the early stages of diabetes (Valensi, 2003). In diabetics, CAN is 
an independent risk factor for chronic kidney disease (Valensi, 2003), mortality 
(Gerritsen et al., 2001; Maser et al., 2003), and coronary heart disease (Liao, Carnethon, 
Evans, Cascio, & Heiss, 2002). Even in the absence of CAN, diabetics have increased 
heart rate and reduced total HRV (Pagani et al., 1988). Reduced RSA is seen even in the 
early stages of diabetes (Faulkner, Hathaway, Milstead, & Burghen, 2001). Additionally, 
Gottsäter, Ahlgren, Taimour, and Sundkvist (2006) found that HRV decreases with the 
15 
duration of Type II diabetes in a population-based sample of adults, and that this decrease 
is more than what would be anticipated by age alone.  
Impaired glucose regulation, an indicator of Type II diabetes (American Heart 
Association, 2007), is related to parasympathetic dysfunction in humans (Takayama, 
Sakura, Katsumori, Wasada, & Iwamoto, 2001). One study found that poor glycemic 
control measured in 1985 independently predicted lower absolute power values of all 
HRV indices ten years later (Makimattila et al., 2000). A negative correlation between 
insulin sensitivity and the ratio of LF/HF spectral power has also been reported 
(Lindmark et al., 2003). Autonomic imbalance is also seen in insulin-resistant individuals 
without diabetes (Flanagan et al., 1999). Low HRV may also predict future development 
of diabetes in both healthy subjects (Carnethon et al., 2003) and non-diabetic offspring of 
Type II diabetics (De Angelis et al., 2001). Lindmark, Wiklund, Bjerle, and Eriksson 
(2003) found that first-degree relatives of patients with Type II diabetes had lower HRV 
and RSA than healthy controls, even though there was no difference between groups on 
fasting blood glucose or glycosylated hemoglobin. 
RSA reactivity hypothesis. There are three main assumptions of the reactivity 
hypothesis. First, reactivity should be a stable trait, and be consistent across stressors and 
situations. Second, reactivity should be a stable trait over time. The third assumption 
states that reactivity should be able to predict resting cardiovascular levels in the future 
(Manuck et al., 1990). In applying RSA to the reactivity hypothesis framework, these 
same assumptions must also hold true. There is evidence supporting the first assumption, 
with moderate to large correlations in RSA reactivity across different tasks (e.g., 
Cacioppo et al., 1994; Salomon, Matthews, & Allen, 2000; Salomon, 2005; Sloan et al., 
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1995; Sloan, Shapiro, Bagiella, & Gorman, 1995). Further, evidence suggests that RSA 
reactivity is temporally stable across months (Sloan, Shapiro, Bagiella, & Gorman, 1995) 
as well as years (Salomon, 2005). Lastly, there is evidence from a sample of children that 
RSA reactivity was predictive of resting levels of blood pressure and RSA at a three year 
follow-up (Matthews et al., 2003; Salomon, 2005). This suggests that RSA reactivity may 
also predict future hypertension and subsequent CVD. Gianaros and colleagues (2005) 
also reported that greater decreases in RSA to a stressor were related to coronary and 
aortic calcification, a subclinical marker of atherosclerosis. However, research is still 
young and more evidence needs to be collected to determine if RSA reactivity is related 
to disease. 
RSA reactivity and biopsychosocial factors. The next step in fitting RSA into a 
reactivity hypothesis framework would require RSA reactivity to be linked to 
biopsychosocial factors that have already been shown to predict disease. Two candidates 
based on prior research would include a genetic susceptibility to CVD, i.e. a positive 
family history, as well as ethnicity. Both of these factors have been linked to an increased 
risk for CVD, and there is supporting evidence for increased sympathetically mediated 
cardiovascular reactivity related to both factors. 
Family History 
Family history and disease risk. A positive family history is typically defined as 
having one or more parents who have been diagnosed with, or prescribed medication for, 
a cardiovascular disorder such as hypertension or coronary heart disease. A negative 
family history is having both parents free of cardiovascular diseases. Positive family 
history is an established risk factor for future development of cardiovascular disease 
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(American Heart Association, 2007). Several epidemiological studies have demonstrated 
an increase risk of hypertension if a family history exists (Harlan, Osborne, & Graybiel, 
1962; Ness, Markovic, Bass, Harger, & Roberts, 2003; Tozawa et al., 2001), and the 
relationship becomes stronger as prevalence within family increases (Tozawa et al., 
2001). To investigate the relationship between family history of cardiovascular disease 
(coronary heart disease, stroke, hypertension, and diabetes) and future onset, Williams 
and colleagues (2001) combined data from two large population-based studies for a total 
of over 130,000 families. Their results showed that although only 14% of families had a 
positive family history of coronary heart disease, 72% of all early coronary heart disease 
happened in these families. Furthermore, while only 11% of families reported a family 
history of stroke, 86% of early strokes occurred in these families. They concluded that 
most cardiovascular events with early onset are seen in people with a positive family 
history of cardiovascular disease.  
Family history and reactivity. Although the mechanisms as to how a family 
history of CVD may lead to the future development of CVD is still unclear, a number of 
researchers have proposed that specific cardiovascular patterns or responses may be 
inherited and that these responses aid in the development of CVD (Fredrikson & 
Matthews, 1990; Manuck, Proietti, Rader, & Polefrone, 1985; Treiber et al., 1993). 
Subsequently, there have been many studies conducted on the relationship between a 
positive family history of hypertension and cardiovascular reactivity to an acute stressor 
in participants who are normotensive (see Pierce, Grim, & King, 2005 for a review). 
Early results indicated that healthy individuals with a positive family history exhibited 
greater reactivity compared to those with a negative family history (Fredrikson & 
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Matthews, 1990; Manuck et al., 1985; Treiber et al., 1993). Treiber and colleagues (1993) 
reported that children with a positive family history had greater reactivity to a cold 
pressor and a video game task. In one study, those with a positive family history had 
increased reactivity to a role-playing task (Holroyd & Gorkin, 1983). Manuck and 
colleagues (1985) found similar results using a mental arithmetic stress task. A meta-
analysis found that individuals with a positive family history of hypertension tend to have 
greater DBP responses to acute stressors (Fredrikson & Matthews, 1990).  
However, several studies have failed to confirm the relationship between family 
history and cardiovascular reactivity (e.g., Anderson, Williams, Lane, Houseworth, & 
Muranaka, 1987; Polefrone & Manuck, 1988; Strickland, Myers, & Lahey, 1989). 
Polefrone and Manuck (1988) investigated the effect of family history in women and 
cardiovascular reactivity to a mental arithmetic and concept-formation task, but found no 
differences between family history groups. Similarly, Strickland, Myers, and Lahey 
(1989) examined parental history of hypertension in black and white females and 
reported no differences in reactivity to a mental arithmetic task. Anderson and colleagues 
(1987) showed contradicting results when they examined reactivity to a mental arithmetic 
stressor in young black females. They reported that subjects with a negative family 
history had greater reactivity. Muldoon and colleagues (1993) reviewed the past 
literature and concluded that a positive family history of hypertension on its own was not 
enough to predict future hypertension, but a positive family history combined with an 
elevated resting SBP was a significant predictor. Another study found that a positive 
family history of hypertension was not significantly related to cardiovascular reactivity in 
healthy individuals, but that a positive family history of CVD in general was related to 
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slower blood pressure recovery and an increase in blood pressure reactivity (Wright, 
O'Donnell, Brydon, Wardle, & Steptoe, 2007). They also found that women with a 
positive family history exhibited higher heart rate and HRV reactivity measures than 
women with a negative family history (Wright et al., 2007). 
Family history and recovery. The literature on cardiovascular recovery and 
family history is limited and inconsistent. For example, Wright and colleagues (2007) 
reported that subjects with a family history had delayed blood pressure recovery 
following a speech stressor and a Stroop task. On the other hand, using a sample of 
normotensive white males, Schneider et al. (2003) reported that those with a negative 
family history had delayed recovery following a mental arithmetic task. Thus, more 
research focusing on family history and recovery is warranted. 
Family History and HRV/RSA Reactivity and Recovery. One study examined 
autonomic differences using adult men and women with either a positive or a negative 
family history of hypertension (Davrath, Goren, Pinhas, Toledo, & Akselrod, 2003). 
They reported that moving from a supine to standing position led to greater LF HRV 
reactivity in the positive family history group when compared to the negative family 
history group. Hatch and colleagues (1986) examined heart period reactivity to tilt, 
mental arithmetic, and cold pressor tasks in normotensive males with and without a 
family history of hypertension. They did not find family history differences in response to 
any of the tasks; however, their sample was limited to eight subjects per group. Miller 
(1994) also examined males with and without a family history of hypertension, who 
underwent several psychological stressors. Although all subjects had RSA reactivity to 
the cold pressor and handgrip tasks, they found no family history group differences to 
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any task. Mezzacappa, Kelsey, Katkin, and Sloan (2001) reported that subjects with a 
positive family history of CVD did not differ from those with a negative family history in 
HRV reactivity to psychological stress tasks. However, they did find a significant 
difference in HRV recovery, with positive family history subjects showing less of a vagal 
rebound compared to negative family history subjects. 
Limitations of Previous Family History Research. Previous literature on family 
history is inconsistent regarding cardiovascular reactivity, and extremely limited 
regarding cardiovascular recovery and RSA reactivity and recovery. Further, there are 
several factors that most family history studies have in common that may have resulted in 
a loss of power and validity. For example, although participants are often relatively 
young, most studies only assess parental history and do not include other relatives such as 
grandparents (e.g., al'Absi, Everson, & Lovallo, 1995; Anderson et al., 1987). This may 
result in an underestimation of familial risk of CVD when research is conducted on 
younger samples such as college students who also have younger parents, because 
symptoms of CVD may not have developed, and it is possible that many parents have yet 
to be diagnosed with a disease when it is in fact present. To resolve this, it has been 
suggested that information be collected on both sets of parents and grandparents 
(Silberberg, Fryer, Wlodarczyk, Robertson, & Dear, 1999). In the medical field, the "gold 
standard" for assessing family history is by including a three-generation pedigree 
interview (Wattendorf & Hadley, 2005), which includes the individual and their parents, 
as well as grandparents, siblings, aunts, and uncles. Several larger studies have 
incorporated this standard into their assessment, including the U.S. Surgeon General's 
Family History Initiative, the Utah Family Health Report, and the Heart of Diabetes 
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study. Further, recording the age of disease onset is often overlooked, but early onset of 
CVD can be useful in identifying individuals with a high familial risk (Taraboanta, 
2008).  
Another limitation occurs when family history of CVD is assessed in the 
laboratory where participants are unable to confer with their relatives. One study reported 
that when black, white, and Hispanic college students were asked to report their family 
history of CVD and diabetes, they had a considerable lack of knowledge (Koutoubi & 
Huffman, 2002). Further, Yoon, Scheuner, and Khoury (2003) stated that take-home 
questionnaires where the individual is able to review family records or confer with 
relatives about their history were more accurate than questionnaires or surveys completed 
on the spot. Another limitation to most previous family history studies is that typically, 
only family history of hypertension is assessed, and not a broader range of cardiovascular 
diseases. 
Ethnicity 
Ethnicity and disease risk. Racial and ethnic disparities are evident in the 
prevalence of CVD. In particular, African Americans have the highest levels of total 
CVD, stroke, hypertension, and obesity. The highest levels of coronary heart disease are 
seen among white males and black females. Although Mexican Americans have the 
lowest total CVD rates of these three ethnic groups, they have higher total cholesterol, 
diabetes, and pre-diabetes rates than Caucasians (American Heart Association, 2007). 
Regarding total CVD, African Americans have the highest rates, with 44.6% of men and 
49% of women over the age of 20 having some form of CVD. White Americans have the 
second highest rates, with 37.2% of men and 35.0% of women having some form of 
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CVD. Hispanics have the lowest rates, with 31.6% of men and 34.4% of women having 
some form of CVD (Rosamond et al., 2008). Cardiovascular disease is the leading cause 
of death across all racial and ethnic groups (Rosamond et al., 2008).  
 Hypertension is an independent risk factor for the development of CVD 
(Rosamond et al., 2008). African Americans have the highest rates of hypertension, while 
hypertension rates for Hispanics and non-Hispanic Whites are similar (Rosamond et al., 
2008). However, Hispanics have the lowest rate of control for hypertension (Ong, 
Cheung, Man, Lau, & Lam, 2007). The incidence of severe hypertension is four times 
higher among black men than white men (Lackland & Keil, 1996). Further, the death 
rates from hypertension are much higher in African Americans (~50 in Blacks, compared 
to 18.1 in total population) (Centers for Disease Control and Prevention, 2004). For first-
time stroke, Blacks have almost twice the risk of Whites (NHLBI, 2006). Further, 
Mexican Americans also have a higher incidence of stroke compared to Whites 
(Morgenstern et al., 2004).  
 Racial and ethnic disparities are seen across most risk factors for cardiovascular 
disease as well. For example, being overweight (BMI >25) or obese (BMI >30) is a risk 
factor for developing CVD. While African American women are the most likely to be 
overweight compared to females of other ethnicities, African American men are the least 
likely to be overweight. Further, while there is little difference in the rates of obesity 
across ethnicity for men (all approximately 30%), there is a disparity seen in females. For 
African American females, ~50% are obese, compared to ~40% of Mexican American 
females and ~30% of White females (Rosamond et al., 2008). 
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Racial and ethnic health disparities are also seen in the rates of diabetes. Data 
from the Center for Disease Control demonstrated that disparities in diabetes are 
particularly evident when comparing Hispanics in the United States and Puerto Rico to 
non-Hispanic Whites, with Hispanics being twice as likely to develop diabetes (9.8%, 
compared to 5.0%) (CDC, 2004). Robbins, Vaccarino, Zhang, and Kasl (2000) reported 
that both Hispanic and Black minority groups are at least twice as likely as Caucasians to 
develop Type II diabetes. Further, death rates from diabetes are twice as high in Blacks 
when compared to Whites (Rosamond et al., 2008).  
Ethnicity and psychosocial risk factors for CVD. There are also social, 
environmental, and psychological risk factors that contribute to CVD risk. One of these is 
socioeconomic status (SES), which is typically assessed using highest education level 
attained and income, and is inversely related to CVD (e.g., Anderson & Armstead, 1995). 
One study that examined coronary heart disease in male civil servants in the United 
Kingdom over a ten-year period found that mortality was inversely related to SES across 
the entire gradient (Marmot & McDowall, 1986). Other studies have confirmed that 
people who are lower in SES are more likely to develop CVD and have more risk factors 
than people higher in SES (Cabrera et al., 2001; Kanjilal et al., 2006; Pickering, 1999). 
Among low-income populations, mortality from CVD is 24% higher than among the 
population as a whole (USDHHS, 1990). This puts certain minority groups at particular 
health risk, as black and Hispanic individuals have lower levels of accumulated wealth, 
less education, higher rates of unemployment, lower income, lower rates of private health 
insurance, and have to rely more on public health care programs than White Americans 
(Ashton et al., 2003; Krieger, Williams, & Moss, 1997). Further, Blacks and Hispanics 
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often have less access to health care (USDHHS, 1990; Yee, et al., 1995). Minority 
individuals are also more likely to have misperceptions about the severity of an illness, 
have inadequate follow-up health care, have fewer blood pressure and cholesterol 
screening, and are less likely to withstand treatment costs (Winkleby, Kraemer, Ahn, & 
Varady, 1998).  
Low SES and other environmental factors all contribute to a high level of daily, or 
chronic, stress. Results from the Malmö Preventative Project showed that chronic stress 
independently predicts CVD, particularly stroke, in men, even after adjusting for other 
known risk factors (Öhlin, Nilsson, Nilsson, & Berglund, 2004). This is particularly 
important to minorities' health, since ethnicity, in addition to being a hereditary risk 
factor, is also a psychosocial factor due to the added stress of discrimination and racism 
(Clark, Anderson, Clark, & Williams, 1999). This is particularly true for minorities in the 
United States, as economic, cultural, social, and historical environments vary greatly 
between racial groups.  
Ethnicity and reactivity. Many studies have attempted to discover differential 
reactivity patterns between Blacks and Whites. As stated previously, exaggerated 
responses to stress may be a marker or a mediator for the development of CVD and 
Blacks are at an increased risk for CVD morbidity and mortality. Anderson and 
colleagues (1993) suggested that, on average, Black Americans encounter greater stress 
on a daily basis than Caucasian Americans, and this extra stress may lead to differential 
cardiovascular reactivity patterns. Further, racism, SES, social support, and various 
personality factors influence reactivity among Blacks (Anderson & Armstead, 1995). 
Racism and discrimination is often considered by researchers to be a chronic social 
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stressor, which has been shown to be related to increased reactivity (Fang & Myers, 
2001; Vrana, 2002). 
Many of the early studies examining racial differences in reactivity were 
conducted by Anderson and his colleagues. One study reported that black men had 
greater cardiovascular reactivity than white men in response to a cold pressor task 
(Anderson, Lane, Muranaka, Williams, & Houseworth, 1988). Treiber et al. (1990) 
reported that black male children and young adults had greater blood pressure reactivity 
than Whites in response to a forehead cold pressor task. A study examining children's 
reactivity over a seven year time period found that black children had greater reactivity 
than white children (Murphy, Stoney, Alpert, & Walker, 1995). Jackson and colleagues 
(1999) evaluated racial differences in 272 black and white children with a positive family 
history of hypertension. Using aggregated reactivity scores from four different stress 
tasks, they found that black children had greater blood pressure reactivity, and less heart 
rate reactivity than white children. 
However, reactivity studies examining racial differences have not yielded 
consistent results (see Anderson, McNeilly, & Myers, 1992 for a review). For example, 
Anderson et al. (1989b) reported that black females had exaggerated SBP responses to a 
cold pressor task than white females, but that there were no significant differences to a 
mental arithmetic task. One study conducted by Anderson et al. (1988) found an opposite 
effect using a mental arithmetic task, where black males had significantly less 
cardiovascular reactivity compared to white males. Other studies have reported no 
significant racial differences. For example, Anderson, Lane, Taguchi, and Williams 
(1989a) found no racial differences in black and white males in response to a mental 
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arithmetic and forehead cold pressor task. Similar results were reported by Morell, 
Myers, Shapiro, Goldstein, and Armstrong (1988) in response to a mental arithmetic task, 
using a sample of black and white males. 
One reason explaining the inconsistent literature may be that blood pressure and 
heart rate measures alone do not portray a complete picture. In other words, while Blacks 
and Whites may be similar in the magnitude of blood pressure reactivity to an acute 
stressor, there may be differences in the hemodynamic profile of the response (Treiber et 
al., 1990). There are many factors that can cause a change in blood pressure, including 
stroke volume, heart rate, and vascular resistance. A more accurate portrayal of racial 
differences can be seen by incorporating impedance cardiography techniques, so that the 
underlying hemodynamics of cardiovascular reactivity can be assessed. After researchers 
started including impedance cardiography, reactivity patterns between Blacks and Whites 
have become somewhat more consistent. More specifically, Blacks tend to show more 
vasoconstrictive reactivity (increase in vascular resistance), while Caucasians exhibit a 
myocardial response (decreased vascular resistance, increased cardiac output, stroke 
volume, and heart rate) (e.g., Light, Turner, Hinderliter, & Sherwood, 1993).  
Although racial group differences in reactivity have shown a generally consistent 
pattern of reactivity between black and white males, reports have been much more 
inconsistent with black and white females. For example, Anderson et al (1989b)  found 
no differences between black and white females in vascular resistance in response to a 
mental arithmetic and forehead cold pressor task. Light et al. (1993) found that black men 
had greater vascular reactivity and white men had greater cardiac output and heart rate 
reactivity, but there was no consistent pattern found for reactivity in black or white 
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females across tasks. Furthermore, in a beta-blockade study using propranolol, there were 
no racial differences observed between black and white females on any cardiovascular 
parameter (Light & Sherwood, 1989).  
While there is a great deal of studies that have examined racial differences 
between Blacks and Whites in cardiovascular reactivity, there has been little research 
examining ethnic reactivity differences using Latinos. This is an important gap in the 
cardiovascular reactivity literature, as Hispanics/Latinos are the fastest growing 
population in the United States, and are now the largest minority group in the U.S. with 
45.5 million people in 2007. Blacks are the second largest minority group with 40.7 
million in 2007 (U.S. Census Bureau, 2008). Hispanics in the U.S. are subjected to many 
of the same daily stressors that are believed to contribute to chronic stress in African 
Americans, such as low SES and discrimination, as well as additional stressors such as 
language barriers, immigration and acculturation issues. 
Ethnicity and recovery. Ethnic differences are also seen in some studies 
examining cardiovascular recovery from stress, although this literature is much more 
limited than the reactivity literature. For example, Treiber et al. (1993) reported that black 
children had impaired blood pressure recovery in response to an exercise and forehead 
cold pressor task. Jackson et al. (1999) reported that black males and females had more 
delayed blood pressure recovery than Whites after stress. Mills and Berry (1999), on the 
other hand, found that black men and women exhibited greater blood pressure recovery 
compared to Whites. Light et al (1993) found that Whites had less heart rate recovery 
than Blacks after a five-minute recovery period. Gillin et al (1996) reported that white 
men had less blood pressure recovery following a speech task than black men and 
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women. Further, Whites had less total peripheral resistance recovery after a mirror-
tracing task compared to Blacks, and white women had the least heart rate recovery 
compared to black women and men. However, due to the limited literature examining 
racial differences in cardiovascular recovery, consistent patterns have not been reported.  
Ethnicity and resting levels of HRV/RSA. Previous literature on the differences 
in HRV between Blacks and Whites is not only limited, but inconsistent as well. For 
example, Zion et al. (2003) examined racial differences in autonomic function and 
reported that Blacks had significantly lower RSA and a higher LF/HF ratio (i.e., 
sympathovagal balance) when compared to non-Blacks. On the other hand, Liao et al. 
(1995) reported that Blacks had significantly lower LF HRV, higher RSA, and higher 
LF/HF ratio when compared to Whites, after adjusting for age and gender. Wang et al. 
(2005) examined black and white adolescents and reported that Blacks had a lower 
LF/HF ratio and higher RSA than Whites, after adjusting for age and heart period. Choi 
et al. (2006) reported that Blacks had lower LF and RSA, but that there were no 
differences in LF/HF ratio. 
Ethnicity and HRV reactivity and recovery. Unfortunately, the literature on 
racial differences in HRV reactivity is even more limited. Urbina et al. (1998) 
investigated HRV reactivity using black and white adolescent males. Subjects underwent 
four stressors, including orthostatic tilt, isometric handgrip task, Valsalva maneuver, and 
a hand cold pressor task. They reported that Blacks had higher RSA values during all 
stressors, and that Whites had higher LF/HF ratio values across all stressors. This 
suggests that Blacks had higher parasympathetic activity and Whites had higher 
sympathetic activity. 
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Current Study 
The CVD epidemic is one that affects all Westernized countries. There are a 
number of factors that are related to the development of CVD, including social, 
biological, psychological, and environmental factors. While there are several known risk 
factors, the cause and etiology of CVD is not completely known. Further, there is even 
less known regarding explanations for the higher prevalence of CVD seen among 
minorities.  
The reactivity hypothesis has been supported throughout the years as a link 
between psychological stress and the development of CVD. However, the reactivity 
hypothesis has largely ignored the parasympathetic contributions to cardiovascular 
reactivity. Resting levels of RSA, a measure of parasympathetic activity, have been 
linked to cardiovascular diseases, as well as diabetes. There are several known risk 
factors for CVD, including a positive family history of CVD and ethnicity. 
Cardiovascular reactivity has been researched for both of these factors, but is limited and 
inconsistent for RSA reactivity. 
The present study attempts to expand the previous research by incorporating RSA 
reactivity into the traditional reactivity hypothesis model and linking it to known 
predictors of CVD, specifically positive family history and ethnicity. Additionally, this 
study will attempt to overcome methodological limitations of previous family history 
studies by assessing the history of CVD in both parents and grandparents, the age of 
onset of disease, and by using a wider definition of CVD that includes hypertension, high 
cholesterol, stroke, diabetes, myocardial infarction, and coronary heart disease. One more 
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unique contribution will be the inclusion of Hispanics, which have been largely ignored 
in the previous reactivity literature. 
Hypotheses: 
1) Participants with a family history of cardiovascular disease will have greater 
reactivity to stress tasks than participants with a negative family history. This will 
be evident in greater decreases in RSA during tasks and greater increases in 
sympathetically mediated responses during tasks. 
2) Participants with a family history of cardiovascular disease will have impaired 
recovery following stress tasks than participants with a negative family history. 
3) Black and Hispanic participants will exhibit greater reactivity to stress tasks 
compared to European American participants. 
4) Black and Hispanic participants will exhibit impaired recovery compared to 
European American participants. 
I also explored interactions between family history and ethnicity on reactivity and 
recovery. However, I did not hypothesize effects specifically as research in this area is 
limited. 
Method 
Participants 
A total of 136 undergraduate females from the University of South Florida 
participated in the study. Of these, 44 were white, 44 were black, 46 were Hispanic, one 
was Middle Eastern, and one was missing ethnicity data. The mean age was 20.8 years 
old. Participants were recruited from the psychology department’s online participant 
pool, Sona Systems, and were compensated with course credit or extra credit in select 
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psychology courses. Participants were excluded from participation if they reported a 
personal diagnosis of cardiovascular disease or arrhythmias, were currently taking any 
medication that might affect the cardiovascular system, reported having diabetes, or who 
reported being pregnant. Further, only participants who knew both of their biological 
parents and who reported having biological parents that were in the same racial/ethnic 
group as the other were included. Bi-racial or multi-racial participants were not included 
in the study. 
Measures 
 Demographic questionnaire. Information regarding participants’ age, household 
income, and ethnicity were collected online via Sona Systems and in the laboratory.   
Family history questionnaire. Family history of cardiovascular disease was 
assessed online via Sona Systems. Participants were asked whether their parents or 
grandparents had ever been diagnosed with or prescribed medication for any of the 
following conditions: Coronary heart disease (such as myocardial infarction, coronary 
bypass graft surgery, or angioplasty), hypertension (high blood pressure), high 
cholesterol, stroke, or diabetes. If applicable, they were asked to further specify whether 
coronary heart disease occurred as early (before age 55) or late (after 55) onset, and 
whether diabetes was Type I or Type II. The questionnaire was completed without any 
time limitations, and the participants could exit and resume the questionnaire from where 
they left off. This made it possible for participants to confer with their parents or other 
relatives if they chose to do so. The family history questionnaire is presented in Appendix 
A. 
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Health questionnaire. Information was collected regarding biological and 
behavioral factors that might affect the cardiovascular system. This included questions on 
previous history of heart disease, arrhythmias, and high blood pressure, as well as 
smoking, caffeine consumption, and exercise. Females were asked to name the first day 
of menstruation during their last cycle. The health questionnaire is presented in Appendix 
B. 
Cardiovascular reactivity tasks 
Cold pressor task. A re-usable ice pack was placed on participants’ foreheads for 
three minutes. The temperature of the ice pack was kept between 0 °C to 3 °C. In the 
event that the task became unbearable, participants were told that they were allowed to 
remove the ice pack. All participants were able to continue the task for the full three 
minutes. This task typically elicits increases in RSA (e.g. Hughes & Stoney, 2000). 
Mental arithmetic task. Participants were instructed to subtract the number 
seven from a four-digit number for three minutes. They were told to do this as quickly 
and accurately as possible, and to say each number aloud. If participants lost their place, 
another four-digit number was assigned to them. This task typically elicits large 
parasympathetic withdrawals (i.e. decreases in RSA) and sympathetic activation (i.e. 
decreases in PEP) (Berntson et al., 1994).  
 Speech task. Participants were asked to prepare and give a speech. Instructions 
were played over an audio speaker describing a scenario where the participant was pulled 
over by a police officer for an unfair traffic violation and is now in traffic court defending 
themselves. They were then given a study card with several points to make during their 
speech and three minutes to quietly prepare. After the preparation period, the 
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experimenter informed them that they would be videotaped and that the quality of their 
speech would be evaluated. They were then given three minutes to deliver their speech. 
This task typically elicits large parasympathetic withdrawals (i.e. decreases in RSA) and 
sympathetic activation (i.e. decreases in PEP) (Berntson et al., 1994). 
Physiological Recording Apparatus  
A Biopac MP150 system with an ECG100 electrocardiogram (ECG) amplifier 
and two RSP100 respiration pneumogram amplifiers (Biopac Systems, Inc., Goleta CA) 
were used to amplify and transducer the ECG and respiration signals. The ECG was 
recorded using Cleartrace LT disposable Ag/AgCl electrodes (Conmed Andover Medical, 
Haverhill, MA), placed in a modified Lead II configuration on the participant’s chest. 
Respiration was recorded using two TSD201 respiratory effort transducers amplified 
using two RSP100C respiration amplifiers (Biopac Systems, Inc., Goleta, CA). One 
transducer was placed around the abdomen and another was placed around the chest. 
Respiratory depth was calibrated against a fixed volume bag. Impedance cardiography 
(ZKG) and the ECG were used for the measurement of pre-ejection period (PEP; an 
indicator of sympathetic activity measured as the contractile force with which the heart 
pumps blood). A Biopac NICO100C (Biopac Systems, Inc., Goleta CA) obtained 
transthoracic impedance waveforms (Z0, dZ/dt) using a tetrapolar lead configuration. 
Disposable aluminum/mylar band electrodes were applied to the neck and chest 
following published guidelines (Sherwood et al., 1990). Current electrodes supply a 4 
mA, 100 kHz signal to the thoracic region. The signals were sampled at 1000 Hz per 
channel by a Dell Optiplex Pentium-4 PC with A/D board. Acquisition and storage of 
ECG, respiration, and impedance cardiography was accomplished using AcqKnowledge 
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3.7.2 software (Biopac Systems, Inc.). Systolic (SBP) and diastolic (DBP) blood pressure 
was measured using an Accutorr Plus non-invasive blood pressure monitor (Datascope 
Corp., Mahwah, NJ) according to published guidelines (Shapiro et al., 1996).  
Experimental Protocol 
Before arriving at the laboratory, participants had completed the online 
questionnaire assessing their family history of cardiovascular disease. Upon arrival, 
participants were greeted by an experimenter and asked to carefully read the informed 
consent form. When participants finished reading the informed consent form, the 
experimenter answered any questions and asked the participant to provide consent by 
signing the form. Participants then completed the health questionnaire. Next, the 
experimenter attached two bands of disposable electrode Mylar tape to the participant’s 
neck and two bands around their torso according to published guidelines (Sherwood et 
al., 1990). The experimenter then used an alcohol swab to clean and prepare the skin 
beneath the right collarbone and the left ribcage before adhering two silver-silver chloride 
electrodes to the skin in a modified lead II configuration.  
Next, participants were led into a small room and seated in a comfortable chair. 
The experimenter attached leads to the Mylar bands and the ECG electrodes and attached 
a blood pressure cuff to the upper part of the participant’s non-dominant arm. Two blood 
pressure readings were taken to make sure the equipment was working properly. The 
experimenter then left the room and instructed the participant to relax while they watched 
a neutral travel film about Alaska for a ten-minute baseline and acclimation period.  
 The three stressor tasks were then administered in counterbalanced order. The 
participant heard instructions through a computer speaker before completing a pre-task 
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appraisal questionnaire. After completing each stressor task, the participant was 
instructed to sit quietly for a 10-minute recovery period before receiving a post-task 
appraisal questionnaire. Once all stressor tasks were completed, the Mylar tape and 
electrodes were removed and the participants’ weight, height, waist, and hip 
measurements were recorded. The participant was thanked for their participation and 
debriefed. 
Data Quantification and Reduction 
 During the baseline, impedance and ECG data was collected during the last five 
minutes, and three blood pressure recordings were taken at minutes 6, 8, and 10. Blood 
pressure readings were taken during minutes 1 and 3 during each of the stressor tasks, 
and on minutes 1, 3, 5, 7, and 9 of the recovery periods. Impedance and ECG data were 
collected continuously throughout each stressor and recovery period.  
RSA was calculated using the MindWare HRV 2.51 Software module (MindWare 
Technologies, Ltd., Gahanna, OH). R-wave markers in the ECG signal was evaluated for 
artifacts by visual inspection and by the MAD/MED artifact detection algorithm 
implemented in the MindWare software (Berntson, Quigley, Jang, & Boysen, 1990). 
Suspected artifacts were corrected manually (<1% of all R-waves in past work needed 
correction). This approach accords with current guidelines for frequency domain methods 
to determine heart rate variability (Berntson et al., 1997; Task Force, 1996). To arrive at 
minute-by-minute estimates of heart rate and RSA during baseline and tasks, a 60-second 
time series of inter-beat intervals (IBIs: the time in milliseconds between sequential ECG 
R spikes) was created from an interpolation algorithm that had a 250-ms sample time. 
This 60-second IBI time series was (a) linearly-detrended, (b) mean-centered, and (c) 
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tapered using a Hamming window. Spectral-power values were determined (in ms
2
/Hz) 
with fast Fourier transformations, and the power values in the 0.15–0.50 Hz spectral 
bandwidth were integrated (ms
2
). These spectral-power values were then natural-log 
transformed prior to statistical analyses because of distributional violations. The natural-
logged spectral-power value in the 0.15–0.50 Hz bandwidth was the indicator of RSA for 
each experimental epoch. Primary measures of RSA reactivity and recovery were the 
arithmetic difference in these scores between task/recovery values and baseline values. 
The MindWare software package was also used to calculate respiration rate from 
spectral analysis of the RSP100C respiration signals. These variables were used as 
control variables to analyze the contribution of respiratory parameters to group 
differences in RSA reactivity and recovery. 
The impedance cardiography values (i.e., PEP) were obtained via ensemble 
averaging of the dZ/dt waveform for each minute of data collected using MindWare IMP 
2.56 software (MindWare Technologies, Ltd., Gahanna, OH). The data were screened for 
artifact by visual inspection of the ensemble-averaged dZ/dt waveforms.   
To calculate reactivity, the RSA and PEP values were first averaged for the three-
minute cold, math, prep, and speech tasks. The arithmetic difference between each task 
segment and the baseline segment was then calculated in order to obtain a reactivity 
score. Thus, each participant had a RSA and PEP change score (i.e. reactivity score) for 
each task. To calculate recovery, participants’ RSA and PEP values during recovery were 
compared to their respective baseline data. Once the average RSA and PEP values were 
calculated for each recovery period, the arithmetic difference from baseline was 
calculated to obtain a recovery change score following each task. 
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Statistical Analyses 
 For Hypothesis 1, a series of one-way between subjects ANCOVAs were 
conducted with family history (FH+, FH-) as the between subjects factor and RSA 
reactivity as the dependent variable. Separate ANCOVAs were run for the math, cold, 
speech preparation, and speech tasks. Age, BMI, baseline RSA, respiration rate, and 
ethnicity were entered as covariates. PEP reactivity was analyzed in a similar fashion; 
however baseline and respiration rate were not included as covariates. 
 For Hypothesis 2, a series of one-way between subjects ANCOVAs were 
conducted with family history (FH+, FH-) as the between subjects factor and RSA 
recovery as the dependent variable. Separate ANCOVAs were run for the math, cold, and 
speech recovery periods. Age, BMI, reactivity, baseline RSA, respiration rate, and 
ethnicity were entered as covariates. PEP recovery was analyzed in a similar fashion; 
however, respiration rate was not used as a covariate. 
 For Hypothesis 3, a series of one-way between subjects ANCOVAs were 
conducted with ethnicity (White, Black, Hispanic) as the between subjects factor and 
RSA reactivity as the dependent variable. Separate ANCOVAs were run for the math, 
cold, speech preparation, and speech tasks. Age, BMI, baseline RSA and respiration rate 
were entered as covariates. PEP reactivity was analyzed in a similar fashion; however 
baseline and respiration rate were not included as covariates. 
For Hypothesis 4, a series of one-way between subjects ANCOVAs were 
conducted with ethnicity (White, Black, Hispanic) as the between subjects factor and 
RSA recovery as the dependent variable. Separate ANCOVAs were run for the math, 
cold, and speech recovery periods. Age, BMI, reactivity, baseline RSA and respiration 
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rate were entered as covariates. PEP recovery was analyzed in a similar fashion; 
however, respiration rate was not used as a covariate. 
For Hypothesis 5, a series of two-way between subjects ANCOVAs were 
conducted with family history (FH+, FH-) and ethnicity (White, Black, Hispanic) as the 
between subjects factors, and RSA reactivity, RSA recovery, PEP reactivity, and PEP 
recovery as the dependent variables. Separate ANCOVAs were run for reactivity to the 
math, cold, speech preparation, and speech tasks, and recovery following the math, cold, 
and speech tasks. For all analyses, age and BMI were included as covariates, with 
baseline RSA and respiration rate added as additional covariates for RSA analyses. For 
recovery analyses, reactivity was covaried. When a significant interaction was observed, 
follow up analyses of the simple effects were conducted.  
All omnibus analyses were run using a significance level of .05. For all analyses, 
the degrees of freedom were adjusted for measures that had incomplete data due to 
technical problems. Each dependent variable was examined for violations of normality. 
Results 
Descriptive statistics 
Family history. Family history was categorized into the following categories 1) 
parental history of hypertension (n = 114), 2) parental history of any of the diseases 
(hypertension, high cholesterol, CVD, stroke, or diabetes) (n = 122), 3) either parental or 
grandparental history of CVD (MI, CHD; n = 80), 4) either parental or grandparental 
history of stroke (n = 76), 5) either parental or grandparental history of Type II diabetes 
(n = 61). These categories were chosen because I felt that they best represented a 
combination of classifications used in previous research (i.e. parental hypertension, 
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family CVD), and classifications that are more novel (i.e. stroke, parents and 
grandparents with diabetes, broad definition of disease for parental history). Other 
categories, such as a broad definition of disease for parents and grandparents, were not 
feasible in the current study because the sample sizes were too small after participants 
with an “unknown” family history were dropped from the analysis. 
For each category, participants were classified as positive family history if any of 
the responses were “yes”. Participants were classified as negative family history if all of 
the responses were “no”. For example, while assessing parental history of any of the 
diseases,  if a participant answered “no” for hypertension, high cholesterol, CVD, and 
stroke, but “I don’t know” for diabetes, they were classified as “unknown” status and 
consequently dropped from further analyses. This is a conservative method, as 
participants with an unknown family history are often classified as negative family 
history (e.g. Wright et al., 2007). A total of n = 22 participants were “unknowns” for 
parental history of hypertension, n = 14 “unknowns” for parental history of any of the 
diseases, n = 56 family history of CVD, n = 60 for family history of stroke, and n = 75 for 
family history of Type II diabetes. See Table 1 for the number of participants in each 
category as well as the racial/ethnic breakdown of each group. 
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Table 1  
Family history (FH) groups 
 
FH Group White Hispanic Black Total 
Parent HT     
 Yes 20 23 22 66 
 No 18 14 15 48 
 Total 38 37 37 114 
 Unknown    22 
Parent Any     
 Yes 28 31 28 89 
 No 12 11 10 33 
 Total 40 42 38 122 
 Unknown    14 
Family CVD     
 Yes 26 17 16 61 
 No 8 6 5 19 
 Total 34 23 21 80 
 Unknown    56 
Family Stroke     
 Yes 13 12 19 45 
 No 14 9 7 31 
 Total 27 21 26 76 
 Unknown    60 
Family Diabetes     
 Yes 11 9 16 36 
 No 12 8 4 25 
 Total 23 17 20 61 
 Unknown    75 
 
Demographic and baseline factors. A series of one-way ANOVA’s were 
conducted assessing the differences between black, white, and Hispanic participants on 
demographic and physical characteristics. The results revealed that the groups did not 
differ on resting baseline PEP or RSA. There were significant effects of ethnicity on 
height, weight, and baseline SBP, DBP, and heart rate (HR). Post hoc tests further 
revealed that Hispanic participants were significantly shorter than white and black 
participants. Black participants were significantly heavier than white and Hispanic 
participants. However, there were no significant differences in BMI. Additionally, black 
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participants had significantly higher resting baseline SBP, DBP, and HR compared to 
Hispanic participants, and slightly higher values when compared to white participants. 
Baseline and demographic characteristics for each racial/ethnic group are presented in 
Table 2. 
Table 2  
Means and standard deviations for demographic and baseline variables by ethnicity 
 
Variable Total White Black Hispanic 
Demographic n = 136 n = 44 n = 44 n = 46 
     Age (yrs) 20.8 (4.4) 21.0 (3.7) 20.5 (2.9) 20.7 (6.0) 
     Mother’s age (yrs) 47.8 (6.7) 49.7 (5.7) 46.7 (5.9) 47.3 (8.1) 
     Father’s age (yrs) 51.1 (6.7) 52.1 (6.3) 50.0 (6.8) 50.6 (6.3) 
     Height (in.) 64.6 (2.4) 65.0 (2.2) 65.1 (2.5) 63.7 (2.4)** 
     Weight (lbs) 142.3 (34.5) 136.9 (23.3) 153.5 (45.0)* 137.6 (30.5) 
     BMI 23.9 (5.1) 22.8 (4.0) 25.3 (6.5) 23.7 (4.3) 
Baseline     
     SBP (mmHg) 108.8 (10.2) 108.5 (9.2) 112.1 (12.1)* 106.2 (8.7) 
     DBP (mmHg) 65.5 (6.7) 65.0 (6.2) 67.7 (7.3)* 63.8 (6.2) 
     HR (bpm) 75.9 (8.6) 75.1 (9.8) 78.5 (8.4)* 74.2 (7.5) 
     PEP (ms) 120.9 (14.8) 123.0 (14.3) 118.1 (16.4) 121.8 (13.8) 
     RSA (ln ms
2
) 6.4 (1.2) 6.3 (1.3) 6.4 (1.1) 6.6 (1.2) 
*p < .05. ** p < .01 
 
Baseline and demographic factors were examined for group differences in each 
family history category using a series of one-way ANOVA’s. For parental history of any 
cardiovascular diseases, participants with a positive parental history had fathers who were 
significantly older than the fathers of participants with a negative family history. For 
family history of CVD, participants with a positive family history had significantly 
higher baseline DBP and PEP values than participants with a negative family history. 
Additionally, participants with a positive family history of diabetes were significantly 
older than participants with a negative family history of diabetes. Means, standard 
deviations, and significance testing information are presented in Tables 3 and 4. 
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Table 3  
Means and standard deviations for demographic variables by family history 
 
 
Parent HT Parent Any 
Family 
CVD 
Family 
Stroke 
Family 
Diabetes 
Variable Yes No Yes No Yes No Yes No Yes No 
Age (yrs) 
20.97 
(4.07) 
21.08 
(5.45) 
21.14 
(4.99) 
20.39 
(3.12) 
21.97 
(5.98) 
19.63 
(1.86) 
21.68 
(6.36) 
20.10 
(2.02) 
20.92* 
(3.06) 
19.40* 
(1.85) 
           
Mother’s 
Age (yrs) 
48.52 
(6.86) 
48.15 
(6.62) 
48.46 
(7.30) 
47.71 
(4.37) 
48.98 
(7.65) 
46.00 
(6.02) 
47.68 
(8.13) 
46.83 
(5.28) 
47.89 
(5.05) 
46.50 
(5.60) 
           
Father’s 
Age (yrs) 
52.16 
(6.52) 
50.02 
(5.94) 
51.98* 
(6.53) 
49.34* 
(5.09) 
51.33 
(7.10) 
50.50 
(6.31) 
50.83 
(8.01) 
49.29 
(5.51) 
51.11 
(5.52) 
48.87 
(6.06) 
           
Height 
(in.) 
64.55 
(2.36) 
65.00 
(2.50) 
64.49 
(2.52) 
64.85 
(2.33) 
64.73 
(2.46) 
64.07 
(2.30) 
64.42 
(2.15) 
64.56 
(2.55) 
64.37 
(2.85) 
64.39 
(2.37) 
           
Weight 
(lbs) 
143.4 
(29.3) 
145.2 
(43.3) 
142.0 
(34.5) 
143.1 
(38.1) 
141.5 
(38.9) 
142.8 
(35.5) 
144.5 
(37.7) 
147.7 
(42.5) 
149.4 
(45.8) 
137.8 
(35.5) 
           
BMI 24.15 
(4.55) 
23.96 
(6.09) 
23.87 
(4.91) 
23.83 
(5.77) 
23.58 
(5.40) 
24.40 
(5.74) 
24.38 
(5.71) 
24.70 
(5.92) 
25.07 
(6.13) 
23.28 
(5.44) 
*p<.05. 
 
Table 4  
Means and standard deviations for baseline variables by family history 
 
 
Parent HT Parent Any 
Family 
CVD 
Family 
Stroke 
Family 
Diabetes 
Variable Yes No Yes No Yes No Yes No Yes No 
SBP 
(mmHg) 
109.0 
(9.3) 
108.1 
(11.8) 
109.2 
(10.6) 
107.0 
(9.5) 
109.8 
(11.1) 
106.3 
(9.5) 
110.6 
(11.5) 
108.2 
(11.4) 
109.6 
(13.0) 
105.7 
(8.5) 
           
DBP 
(mmHg) 
65.4 
(6.4) 
65.2 
(7.0) 
65.9 
(7.0) 
64.4 
(5.4) 
66.6 
(7.3) 
62.6 
(6.1) 
67.1 
(6.1) 
65.0 
(8.0) 
66.0 
(8.4) 
63.1 
(6.0) 
           
HR 
(bpm) 
75.8 
(7.9) 
75.7 
(9.8) 
76.2 
(8.3) 
74.1 
(9.7) 
75.6 
(8.9) 
77.2 
(8.8) 
76.8 
(8.5) 
77.2 
(9.1) 
76.4 
(9.1) 
76.9 
(8.9) 
           
PEP (ms) 118.2 
(13.4) 
123.6 
(16.1) 
120.3 
(14.6) 
122.5 
(14.7) 
124.1* 
(15.5) 
115.4* 
(14.1) 
120.9 
(12.7) 
119.2 
(16.8) 
120.7 
(13.7) 
118.8 
(16.7) 
           
RSA 6.46 
(1.16) 
6.36 
(1.25) 
6.37 
(1.22) 
6.54 
(1.12) 
6.17 
(1.23) 
6.59 
(0.83) 
6.47 
(1.23) 
6.27 
(0.90) 
6.75 
(0.94) 
6.26 
(1.07) 
*p<.05 for yes/no comparison. 
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Reactivity and Recovery Patterns 
 A series of paired t-tests were conducted in order to test for significant changes in 
PEP, RSA, and HR from baseline both during each of the stress tasks and throughout 
each of the recovery periods. See Table C1 in appendix for means and significance 
testing. As can be seen in Figures 1-3, the tasks were effective in evoking significant 
autonomic responses. During the speech preparation and speech delivery tasks, 
participants exhibited sympathetic activation and parasympathetic withdrawal, as seen by 
significant decreases in RSA and PEP, as well as significant increases in HR. During the 
math task, there was significant sympathetic excitation, as indicated by decreases in PEP 
and increases in HR; however, RSA did not differ from baseline. During the cold task, 
both parasympathetic and sympathetic activation occurred, reflected by significant RSA 
increases, and significant decreases in PEP and HR. It is important to note that decreases 
in PEP (i.e. heart contractility) indicate greater sympathetic activation. 
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Figure 1. RSA Reactivity Scores by Task. *p<.05. 
 
 
Figure 2. PEP Reactivity Scores by Task. *p<.05. 
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Figure 3. HR Reactivity Scores by Task. *p<.05. 
There were also significant differences from baseline in RSA, PEP, and HR 
during the recovery periods, as seen in Figures 4-6. During the speech and math recovery 
periods participants exhibited parasympathetic and sympathetic activity greater than in 
their resting state, as RSA remained significantly elevated and PEP remained 
significantly decreased, while HR had returned to baseline. During the cold recovery 
period, a similar pattern was seen, with greater sympathetic and parasympathetic activity 
compared to baseline, as demonstrated by RSA that remained significantly elevated from 
baseline, both PEP, and HR that remained significantly decreased.  
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Figure 4. RSA Recovery Scores by Task. *p<.05. 
 
 
Figure 5. PEP Recovery Scores by Task. *p<.05. 
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Figure 6. HR Recovery Scores by Task. *p<.05. 
Hypothesis 1: Family History on RSA and PEP Reactivity 
I hypothesized that participants with a family history of CVD would have greater 
RSA and PEP reactivity to stress tasks than participants with a negative family history. In 
order to determine the effect of a positive family history of CVD on cardiovascular 
reactivity to the stress tasks, one-way ANCOVAs with family history as the between 
subjects factor and each physiological reactivity score as the dependent variable were 
conducted. For all PEP analyses, age, BMI, and ethnicity were entered as covariates. For 
all RSA analyses, age, BMI, ethnicity, respiration, and baseline RSA values were entered 
as covariates.  
Parental history of hypertension. There was no effect of parental hypertension 
on RSA reactivity for the math, prep, or speech tasks (p’s > .10). For the cold task, the 
main effect of parental history of hypertension was significant, F(1, 102) = 5.41, p = 
.022. Participants with a positive family history had greater increases in RSA (M = 0.540, 
SE = 0.072) than participants with a negative family history (M = 0.280, SE = 0.084). 
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There was no effect of parental hypertension on PEP reactivity for any of the tasks (p’s > 
.10).  
Parental history of any of the cardiovascular diseases. There was no effect of 
parental history of disease on RSA reactivity for the math, prep, or speech tasks (p’s > 
.10). For the cold task, the main effect of parental history of disease was significant, F(1, 
110) = 6.72, p = .011. Participants with a positive family history had greater increases in 
RSA (M = 0.512, SE = 0.061) than participants with a negative family history (M = 
0.210, SE = 0.099). There was no effect of parental history of disease on PEP reactivity 
for any of the tasks (p’s > .10).  
Family history of CVD. There were no significant effects of family history of 
cardiovascular disease on RSA or PEP reactivity to any of the tasks (p’s > .10).  
Family history of stroke. There was no effect of family history of stroke on RSA 
or PEP reactivity to the cold, math or prep tasks (p’s > .10). For the speech task, the main 
effect of family history of stroke on RSA reactivity was significant, F(1, 64) = 9.50, p = 
.003. Participants with a positive family history of stroke had greater decreases in RSA 
(M = -0.677, SE = 0.129) than participants with a negative family history (M = -0.033, SE 
= 0.157). Similarly, the main effect of family history of stroke on PEP reactivity was 
significant for the speech task, F(1, 63) = 5.41, p = .023. Participants with a positive 
family history had greater decreases in PEP (M = -22.42, SE = 2.22) than participants 
with a negative family history (M = -14.15, SE = 2.68). 
Family history of Type II diabetes. There was no effect of family history of 
Type II diabetes on RSA reactivity to the cold task (p > .10). The effect of family history 
of Type II diabetes on RSA cold task reactivity showed trends for the math, prep, and 
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speech tasks. For the math task, participants with a positive family history had greater 
decreases in RSA (M = -0.363, SE = 0.155) than participants with a negative family 
history (M = 0.127, SE = 0.192), F(1, 52) = 3.43, p = .070. For the prep task, participants 
with a positive family history had greater decreases in RSA (M = -0.442, SE = 0.131) 
than participants with a negative family history (M = -0.015, SE = 0.162), F(1, 52) = 
3.76, p = .058. Similar trends were seen for the speech task, where participants with a 
positive family history had greater decreases in RSA (M = -0.603, SE = 0.159) than 
participants with a negative family history (M = -0.101, SE = 0.196), F(1, 52) = 3.51, p = 
.067. 
There was no effect of family history of Type II diabetes on PEP reactivity for the 
math task (p > .10). The effect of family history of Type II diabetes on PEP reactivity 
showed trends for the prep, speech, and cold tasks. For the prep task, participants with a 
positive family history had greater decreases in PEP (M = -16.67, SE = 2.23) than 
participants with a negative family history (M = -10.21, SE = 2.61), F(1, 51) = 3.24, p = 
.078. For the speech task, participants with a positive family history had greater decreases 
in PEP (M = -23.58, SE = 2.66) than participants with a negative family history (M = -
15.51, SE = 3.16), F(1, 52) = 3.55, p = .065. Following the same trend, during the cold 
task participants with a positive family history had greater decreases in PEP (M = -3.05, 
SE = 1.10) than participants with a negative family history (M = -0.02, SE = 1.29), F(1, 
51) = 2.93, p = .093.  
Hypothesis 2: Family History on RSA and PEP Recovery 
I hypothesized that participants with a family history of cardiovascular disease 
would have impaired recovery following stress tasks than participants with a negative 
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family history. In order to determine the effect of a positive family history of CVD on 
RSA and PEP recovery following the stress tasks, one-way ANCOVAs with family 
history as the between subjects factor and each physiological recovery score as the 
dependent variable were conducted. For all PEP analyses, PEP reactivity, age, BMI, and 
ethnicity were entered as covariates. For all RSA analyses, RSA reactivity, baseline RSA, 
age, BMI, ethnicity, respiration, and baseline RSA values were entered as covariates.  
For a family history of stroke, there was a trend for group differences on PEP 
recovery following the cold task, F(1, 62) = 3.29, p = .075. Participants with a positive 
family history had smaller PEP decreases (M = -2.40, SE = 0.64) than participants with a 
negative family history (M = -4.31, SE = 0.80). There were no other significant effects of 
family history on PEP or RSA recovery for any of the tasks (p’s > .10). 
Hypothesis 3: Ethnicity on RSA and PEP Reactivity 
I hypothesized that black and Hispanic participants would exhibit greater 
reactivity compared to European American participants. In order to determine the effect 
of ethnicity on RSA and PEP reactivity to the stress tasks, one-way ANCOVAs with 
ethnicity as the between subjects factor and each physiological reactivity score as the 
dependent variable were conducted. For all PEP analyses, age and BMI were entered as 
covariates. For all RSA analyses, age, BMI, respiration, and baseline RSA values were 
entered as covariates.  
There was no effect of ethnicity on RSA or PEP reactivity for any of the tasks (p’s 
> .10).  
 
 
51 
Hypothesis 4: Ethnicity on RSA and PEP Recovery 
I hypothesized that black and Hispanic participants would exhibit impaired 
recovery compared to European American participants. In order to determine the effect of 
ethnicity on RSA and PEP recovery following the stress tasks, one-way ANCOVAs with 
ethnicity as the between subjects factor and each physiological recovery score as the 
dependent variable were conducted. For all PEP analyses, PEP reactivity, age, and BMI 
were entered as covariates. For all RSA analyses, RSA reactivity, baseline RSA, age, 
BMI, respiration, and baseline RSA values were entered as covariates. 
There were no significant effects of ethnicity on RSA recovery for the math or 
cold tasks (p’s > .10). However, the effect of ethnicity on RSA recovery was significant 
following the speech task, F(2, 120) = 3.45, p = .035. A Tukey’s HSD revealed that RSA 
changes were smaller in black participants compared to white (p = .013) and Hispanic 
participants (p = .053), see Figure 7. There were no significant effects of ethnicity on PEP 
recovery for any of the tasks (p’s > .10). 
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Figure 7. RSA Recovery after Speech Task as a Function of Ethnicity 
Hypothesis 5a: Family History and Ethnicity on RSA and PEP Reactivity  
I did not hypothesize specific effects, as research in this area is limited. In order to 
explore the interactions between family history and ethnicity, separate 2x3 ANCOVAs 
were run for each task with family history and ethnicity as the between subjects factors 
and each physiological reactivity score as the dependent variable. For all PEP analyses, 
age and BMI were entered as covariates. For all RSA analyses, age, BMI, respiration, and 
baseline RSA values were entered as covariates. 
Parental history of hypertension. For the cold task, the main effect of parental 
history of hypertension on RSA reactivity was significant, F(1, 99) = 6.59, p = .012. 
Those with hypertensive parents had greater reactivity (M = 0.539, SE = 0.071) than 
those with normotensive parents (M = 0.253, SE = 0.084). There was a trend for the main 
effect of ethnicity, F(2, 99) = 2.38, p = .098. Black participants (M = 0.219, SE = 0.099) 
had lower RSA reactivity than white (M = 0.487, SE = 0.094, p = .059) and Hispanic (M 
= 0.482, SE = 0.097, p = .061) participants. The interaction between family history and 
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ethnicity showed a trend, F(2, 99) = 2.47, p = .09. There was a significant simple effect 
of family history for black participants, F(1, 99) = 4.75, p = .032. Those with a positive 
family history had significantly greater reactivity than those with a negative family 
history. Similarly, there was a significant simple effect of family history for Hispanic 
participants, F(1, 99) = 6.18, p = .015. Those with a positive family history had 
significantly higher reactivity than those with a negative family history (see Figure 8). 
There were no significant effects of parental history of hypertension or ethnicity on PEP 
reactivity to any of the tasks, p’s  > .10. 
 
Figure 8. RSA Reactivity to the Cold Pressor Task as a Function of Parental History of 
Hypertension and Ethnicity, p < .05 for FH+/- comparison. 
Parental history of any of the cardiovascular diseases. For the cold task, there 
was a significant main effect of family history, F(1, 107) = 8.00, p = .006. Participants 
with a positive parental history of any of the diseases had greater reactivity (M = 0.507, 
SE = 0.060) than those with disease-free parents (M = 0.180, SE = 0.098). There was also 
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a significant main effect of ethnicity on RSA reactivity, F(2, 107) = 3.64, p = .029. Black 
participants had significantly lower reactivity (M = 0.114, SE = 0.109) than Hispanic (M 
= .409, SE = 0.098, p = .046) and white participants (M = 0.506, SE = 0.098, p = .01). 
The interaction showed a trend, F(2, 107) = 2.60, p = .079, see Figure 9. There were 
significant simple effects of family history for black participants, F(1, 107) = 5.27, p = 
.024. Black participants with a family history had significantly greater RSA reactivity 
than those without a family history. Similarly, there were significant simple effects of 
family history for Hispanic participants, F(1, 107) = 7.07, p = .009. Hispanic participants 
with a family history had significantly greater RSA reactivity than those without a family 
history. There were no significant effects of parental history of disease or ethnicity on 
PEP reactivity to any of the tasks, p’s  > .10. 
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Figure 9. RSA Reactivity to the Cold Pressor Task as a Function of Parental History of 
Hypertension, High Cholesterol, CVD, or Diabetes and Ethnicity, p < .05 for FH+/- 
comparison. 
Family history of CVD. There were no significant effects of family history of 
CVD or ethnicity on RSA or PEP reactivity to any of the tasks, p’s > .10. 
Family history of stroke. For the speech task, there was a significant main effect 
of family history of stroke on RSA reactivity, F(1, 61) = 10.56, p = .002. Participants 
with a family history of stroke had greater decreases in RSA (M = -0.685, SE = 0.134) 
than people without a family history (M = 0.024, SE = 0.167). Ethnicity was not a 
significant main effect. Further, there was a significant main effect of family history of 
stroke on PEP reactivity during the speech task, F(1, 60) = 8.26, p = .006. Participants 
with a family history of stroke had greater decreases in PEP (M = -23.14, SE = 2.24) than 
people without a family history (M = -12.77, SE = 2.74). There was also a significant 
main effect for ethnicity, F(2, 60) = 3.14, p = .05. Black participants had significantly 
smaller decreases in PEP (M = -11.26, SE = 3.40) than white participants (M = -22.48, SE 
0.525
-0.132
0.147
0.488
0.36
0.672
-0.4
-0.2
0
0.2
0.4
0.6
0.8
1
White Black Hispanic
Δ
lo
g
 m
s2
FH-
FH+
*
*
56 
= 2.82, p = .017) and slightly smaller decreases than Hispanic participants (M = -20.13, 
SE = 3.06, p = .062). 
Family history of Type II diabetes. For the math, prep, and speech tasks, there 
was a trend for the main effect of family history of diabetes on RSA reactivity. For the 
math task, participants with a family history of Type II diabetes had greater decreases in 
RSA (M = -0.351, SE = 0.158) than people without a family history (M = 0.190, SE = 
0.206), F(1, 49) = 3.93, p = .053. Similarly, participants with a family history of Type II 
diabetes had greater decreases in RSA (M = -0.451, SE = 0.133) than people without a 
family history (M = -0.006, SE = 0.172) for the prep task, F(1, 49) = 3.91, p = .054. 
Following the same trend, for the speech task participants with a family history of Type II 
diabetes had greater decreases in RSA (M = -0.601, SE = 0.164) than people without a 
family history (M = -0.100, SE = 0.215), F(1, 49) = 3.17, p = .081. 
The main effect for family history of diabetes on PEP reactivity showed a trend 
for the prep task, F(1, 48) = 3.60, p = .064. Participants with a family history of diabetes 
had greater decreases in PEP (M = -16.60, SE = 2.28) than people without a family 
history (M = -9.62, SE = 2.78). Further, there was a significant main effect for family 
history of diabetes on PEP reactivity for the speech task, F(1, 49) = 4.71, p =.035. 
Participants with a family history of diabetes had greater decreases in PEP (M = -23.40, 
SE = 2.68) than people without a family history (M = -13.92, SE = 3.55).  
Hypothesis 5b: Family History and Ethnicity on RSA and PEP Recovery  
I did not hypothesize specific effects, as research in this area is limited. In order to 
explore the interactions between family history and ethnicity, separate 2x3 ANCOVAs 
were run for each task with family history and ethnicity as the between subjects factors 
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and each physiological recovery score as the dependent variable. For all PEP analyses, 
PEP reactivity, age and BMI were entered as covariates. For all RSA analyses, RSA 
reactivity, age, BMI, respiration, and baseline RSA values were entered as covariates. 
Parent history of hypertension. Following the speech task, there was a 
significant main effect of ethnicity on RSA recovery, F(2, 95) = 3.60, p = .031. A 
Tukey’s HSD indicated that black participants (M = -0.085, SE = 0.074) had significantly 
lower RSA recovery values than white (M = 0.182, SE = 0.068, p = .01) and Hispanic (M 
= 0.112, SE = 0.07, p = .06) participants.  
Parent history of any of the cardiovascular diseases. There was a significant 
effect of ethnicity on RSA recovery after the speech task, F(2, 103) = 3.66, p = .029. 
Tukey’s HSD test further revealed that black participants (M = -0.088, SE = 0.085) had 
significantly lower RSA values than white participants (M = 0.215, SE = 0.072, p = .008) 
and slightly lower than Hispanic participants (M = 0.118, SE = .073, p = .071).  
Family history of CVD. Following the cold task, the main effect of ethnicity on 
RSA recovery showed a trend, F(2, 65) = 2.58, p = .084. Black participants had the 
highest RSA values (M = 0.392, SE = 0.102) followed by Whites (M = 0.125, SE = 
0.079) and Hispanics (M = 0.099, SE = 0.092). Following the speech task, the main effect 
of ethnicity on RSA recovery showed a trend, F(2, 64) = 2.57, p = .085. White 
participants (M = 0.274, SE = 0.09) had higher RSA values than black participants (M = -
0.026, SE = 0.119, p = .051) and Hispanic participants (M = 0.037, SE = 0.106, p = .089). 
There was a significant effect for the ethnicity by family history interaction, F(2, 64) = 
3.74, p = .029. The simple effect of family history showed a trend for white participants, 
F(1, 64) = 3.46, p = .068. Those with a negative family history had higher RSA values 
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than those with a positive family history. The simple effect of family history also showed 
a trend for Hispanic participants, F(1, 64) = 3.80, p = .056. However, the opposite pattern 
was seen, where those with a positive family history had higher RSA values than those 
with a negative family history, see Figure 10.  
 
Figure 10. RSA Recovery after the Speech Task as a Function of Family History of CVD 
and Ethnicity, p < .1 for FH+/- comparison 
Family history of stroke. Following the math task, there was a main effect of 
family history on RSA recovery, F(1, 60) = 4.05, p = .049. Participants with a positive 
family history had significantly higher RSA (M = 0.189, SE = 0.065) than participants 
with a negative family history (M = -0.028, SE = 0.083). There was a trend for the main 
effect of ethnicity, F(2, 60) = 2.72, p = .074. White participants had higher RSA (M = 
0.236, SE = 0.081), than Hispanic (M = 0.083, SE = 0.093) and black participants (M = -
0.077, SE = 0.103). The ethnicity by family history interaction on RSA recovery was 
significant, F(2, 60) = 3.61, p = .033. The simple effect of family history was significant 
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for black participants, F(1, 60) = 9.19, p = .004. Black participants with a negative family 
history had greater decreases in RSA compared to participants with a positive family 
history.  
 
Figure 11. RSA Recovery after the Speech Task as a Function of Family History of 
Stroke and Ethnicity, p < .05 for FH+/- comparison 
Following the speech task, the main effect of ethnicity on RSA recovery showed a 
trend, F(2, 58) = 2.92, p = .062. White participants (M = 0.259, SE = 0.088) had 
significantly higher RSA values than black participants (M = -0.109, SE = 0.120, p = .02), 
but were not statistically different from Hispanic participants (M = 0.102, SE = 0.099, p = 
.239). Additionally, there was a trend for the main effect of family history on PEP 
recovery following the cold task, F(1, 59) = 3.32, p = .073. Participants with a negative 
family history had greater decreases in PEP (M = -4.44, SE = 0.85) than participants with 
a positive family history (M = -2.43, SE = 0.67).  
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Family history of Type II diabetes. Following the speech task, the main effect 
of ethnicity on RSA recovery showed a trend, F(2, 47) = 3.07, p = .056. Black 
participants (M = -0.255, SE = 0.128) had significantly lower RSA values than white 
participants (M = 0.146, SE = 0.099, p = .017), and slightly lower than Hispanic 
participants (M = 0.017, SE = 0.110, p = .115).  
Discussion 
 Previous research has shown that exaggerated reactivity and delayed recovery is 
predictive of the future development of cardiovascular-related diseases. Further, people 
who have a heightened risk for the development of cardiovascular diseases have shown 
greater reactivity and impaired recovery to stressful tasks. The primary purpose of the 
present study was to examine the associations between ethnicity, a family history of 
cardiovascular and related diseases, and autonomic reactivity and recovery to three stress 
tasks. 
 In general, the results observed supported the hypothesis that a positive family 
history was related to greater reactivity; however, the hypothesis that a positive family 
history would lead to impaired recovery was only partially supported. The results 
indicated that ethnicity was related to reactivity and recovery, but in the opposite 
direction than was expected. The following discussion will evaluate the findings of the 
present study with regard to the specific research hypotheses, as well as the study’s 
limitations, implications, and directions for future research.  
Baseline and Demographic Factors 
 There were no significant differences in baseline measures of SBP, DBP, HR, 
PEP, or RSA between participants with a positive and negative parental history of 
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hypertension, parental history of any cardiovascular or related diseases, family history of 
stroke, or family history of Type II diabetes. There were significant differences between 
resting levels of PEP between participants with a positive and negative family history of 
CVD, however the effect was opposite of what we would expect. That is, participants 
with a negative family history of CVD had higher sympathetic activation of the heart at 
rest. On the other hand, participants with a positive family history of CVD exhibited 
higher resting DBP levels. This may indicate a larger afterload (i.e. higher pressure), 
which would result in a slowing of PEP. Previous studies have found that participants 
with a positive parental history of hypertension exhibit a combination of increased 
sympathetic activity (e.g. SBP) and decreased parasympathetic activity (e.g. HF-HRV) at 
rest (Maver, Strucl, & Accetto, 2004). However, these differences may be explained 
through sample characteristics, as Maver, Strucl, and Accetto (2004) used a sample with 
a mean age of 28.6 years, while the current study had a mean age of 20.8 years.  
Evaluation of Specific Aims 
 Family history and reactivity. One aim of the current study was to examine the 
affect of a positive family history of cardiovascular disease on autonomic reactivity to 
psychological stress. I hypothesized that participants with a positive family history would 
exhibit an exaggerated response to the stress tasks compared to participants with a 
negative family history. This was expected as an increase in parasympathetic activity 
during the cold task, and a decrease in parasympathetic activity combined with an 
increase in sympathetic activity during the math and speech tasks.  
 Parental history of hypertension/any of the diseases. The results were practically 
identical between these two categories of family history, so they will be presented 
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together. As hypothesized, a positive parental history of hypertension or other 
cardiovascular diseases was related to greater parasympathetic reactivity. This was 
evidenced by greater RSA increases during the cold task among participants with a 
positive parental history. However, this effect was modified by ethnicity, as it was only 
observed in black and Hispanic participants. In this study, there was no effect of parental 
history of hypertension or other related diseases on autonomic reactivity for white 
participants. This finding contradicts previous studies conducted on Whites. For example, 
Miller (1994) examined RSA reactivity in participants with and without a parental history 
of hypertension using four stress tasks, including the cold pressor task. He found no 
family history differences in RSA across any of the tasks. Wright, O’Donnell, Brydon, 
Wardle, and Steptoe (2007) also reported no effects of family history of hypertension on 
DBP, HR, or HRV reactivity to a Stroop color word or speech task.  
Additionally, there were no significant effects of parental history of disease on 
sympathetic reactivity to any of the tasks. This was surprising, as previous studies have 
generally reported greater reactivity in measures linked to sympathetic activation in 
offspring of hypertensives. For example, Frazer, Larkin, and Goodie (2002) reported that 
undergraduate males and females with a parental history of hypertension had greater SBP 
reactivity to mental arithmetic, mirror tracing, and role-playing tasks compared to 
participants with a negative family history. One study using a sample of 11-14 year old 
males found greater DBP reactivity to a cold pressor (Musante, Treiber, Strong & Levy, 
1990). Another study found a significant effect of parental history of hypertension on HR 
and DBP reactivity to a mental arithmetic task (Manuck, Proietti, Rader, & Polefrone, 
1985). A meta-analysis conducted by Fredrikson and Matthews (1990) reported that 
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normotensive participants with hypertensive parents demonstrated greater SBP and HR 
responses to active- (e.g. speech, mental arithmetic) and passive-(e.g. cold pressor) 
coping stressors, as well as greater DBP responses to passive-coping stressors. However, 
they also reported that studies on offspring that were older (over 20 years) had more 
significant and more reliable increases in reactivity (Fredrikson & Matthews, 1990). The 
current sample had a mean age (M = 20.8) right around their cut-off for “older” vs. 
“younger” participants, which may explain some of the differences in our findings. 
Family history of cardiovascular disease. Contrary to expectations, there was no 
significant effect of family history of cardiovascular disease on parasympathetic or 
sympathetic reactivity to any of the tasks. This was unexpected, as previous studies have 
shown a relationship between reactivity and family history of CVD. One study measured 
autonomic reactivity to a mental arithmetic and an anger induction task in participants 
with a family history of CVD (Nelson, Franks, Brose, Raven, Williamson, Shi, McGill, & 
Harrell, 2005). They found that participants with a positive family history had less 
parasympathetic activity during the anger induction task, but the effect was only 
significant in participants who were also high on trait hostility (Nelson et al., 2005). 
Wright, O’Donnell, Brydon, Wardle, and Steptoe (2007) found that participants with a 
positive family history of CVD had greater DBP reactivity to a Stroop task, and that 
women with a positive family history had greater parasympathetic withdrawals during 
Stroop and speech tasks. Nelson and colleagues (2005) proposed that parasympathetic 
variation is the primary factor that accounts for the differences seen between the positive 
and negative family history of CVD groups. However, Nelson et al. (2005) and Wright et 
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al. (2007) failed to control for respiration when examining RSA reactivity, as 
recommended by Bernston et al. (1997).  
Family history of stroke. A positive family history of stroke was related to 
significantly greater parasympathetic withdrawal coupled with greater sympathetic 
activation to the speech task, as demonstrated by greater RSA and PEP decreases in the 
positive family history group. To my knowledge, no other studies have been conducted 
examining autonomic reactivity to an acute stressor in participants with a family history 
of stroke. The results here clearly demonstrate exaggerated reactivity in both the 
sympathetic and parasympathetic nervous systems. It is interesting, as the degree of 
family history is strongly related to the future incidence of stroke (Williams et al., 2001), 
and the risk factors for stroke are very similar to other cardiovascular diseases, such as 
age, African-American ethnicity, and hypertension (Sturgeon, Folsom, Longstreth, 
Shahar, Rosamund, & Cushman, 2007). 
Family history of Type II diabetes. A positive family history of Type II diabetes 
was related to exaggerated reactivity. This was evidenced by greater parasympathetic 
withdrawal to the math task, and greater parasympathetic withdrawal coupled with 
greater sympathetic activation to the prep and speech tasks. There was also a trend for 
greater sympathetic activity during the cold pressor. These would support my hypothesis; 
however, these effects were only of borderline significance. Altered autonomic control of 
the heart and exaggerated autonomic reactivity are commonly reported in offspring of 
Type II diabetics. One study reported that participants with a positive family history of 
Type II diabetes were more likely to have autonomic neuropathy (i.e., decreased 
parasympathetic control) compared to participants without a family history, even after 
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adjusting for known confounding and risk factors such as age, SBP, DBP, BMI, 
cholesterol, glucose, and insulin (Foss, Vestbo, Froland, Gjessing, Mogensen, & 
Damsgaard, 2001). Greater sympathetic activation has also been reported among non-
diabetic offspring of Type II diabetics, and sympathetic activity was correlated with 
plasma insulin and insulin resistance but only in participants with a positive family 
history of diabetes (Huggett, Hogarth, Mackintosh, & Mary, 2006). Further, another 
study reported that participants with a parental history of Type II diabetes combined with 
insulin resistance had blunted RSA reactivity to a cold pressor task, while offspring who 
had normal insulin sensitivity had increases in RSA during the task (Lindmark, Wiklund, 
Bjerle, & Eriksson, 2003).  
Ethnicity and reactivity. A second aim of the current study was to examine the 
effect of ethnicity on sympathetic and parasympathetic reactivity to psychological stress. 
I hypothesized that participants who were black would exhibit an exaggerated response to 
the stress tasks compared to white and Hispanic participants. These would be exhibited as 
an increase in parasympathetic activity during the cold task, and a decrease in 
parasympathetic activity combined with an increase in sympathetic activity during the 
math and speech tasks.  
The results were the opposite of what I hypothesized. As can be seen in the 
factorial ANCOVAs, after the variance attributed to family history was removed, black 
participants exhibited less reactivity compared to white and Hispanic participants. More 
specifically, during the cold task, black participants had less parasympathetic activation, 
as evidenced by smaller increases in RSA, than white or Hispanic participants. 
Additionally, black participants had less sympathetic activation during the speech task, as 
66 
evidenced by smaller decreases in PEP. As described in the implications section, this 
indicates a blunted reactivity response that has been associated with chronic stress 
(McEwen & Seeman, 1999). It is important to point out that this research area is still 
relatively new, and the distinction between what causes exaggerated vs. blunted reactivity 
patterns has yet to be fully explained.   
Family history and recovery. Another aim of the current study was to examine 
the affect of a positive family history of cardiovascular disease on autonomic recovery 
following an acute psychological stressor. I hypothesized that participants with a positive 
family history would exhibit an impaired recovery response following the stress tasks 
compared to participants with a negative family history. Due to the restorative effects of 
parasympathetic activity, I expected impaired RSA to be demonstrated by a failure to 
rebound to levels greater than baseline following the three stress tasks, and sympathetic 
activity above baseline following the math and speech tasks. 
 Parental history of hypertension/any of the diseases. There were no significant 
effects of parental history of disease on parasympathetic or sympathetic recovery 
following any of the tasks. This was surprising, as previous studies have reported 
impaired recovery, particularly in sympathetically controlled measures such as DBP and 
PEP (e.g., Schneider, Jacobs, Gevirtz, and O’Connor, 2003).  
Family history of CVD. There was a significant effect of family history of CVD 
on parasympathetic recovery following the speech task; however, this effect was 
modified by ethnicity. More specifically, for white participants, a positive family history 
was related to rebound of RSA to levels greater than baseline while participants with a 
negative family history had RSA levels around baseline, thus failing to rebound. The 
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opposite effect was seen in Hispanic participants, such that participants with a positive 
family history of CVD did not return to baseline levels while participants with a negative 
family history exhibited RSA rebound. Mezzacappa, Kelsey, Katkin, and Sloan (2001) 
reported that participants with a positive family history of CVD demonstrated 
significantly smaller vagal rebound after a math task than participants with a negative 
family history, but that there were no significant family history effects on 
parasympathetic withdrawal during the stressor. The findings in the current study are 
similar, however only for Hispanic participants. Another study found that participants 
with a family history of CVD had impaired SBP and DBP recovery, but there were no 
differences in rMSSD (i.e. RSA) (Wright, O’Donnell, Brydon, Wardle, & Steptoe, 2007), 
however the effects may be distorted since their family history classification included 
“unknown” family history as “negative” family history and was not as conservative as the 
current study. 
Family history of stroke. There was a significant effect of family history of stroke 
on parasympathetic recovery following the math task, but only for black participants. In 
particular, black participants with a positive family history of stroke exhibited RSA 
rebound, while black participants with a negative family history of stroke had RSA levels 
that failed to return to baseline. Additionally, there was a trend for participants with a 
negative family history of stroke to have impaired sympathetic recovery, as indicated by 
greater decreases in PEP. 
Family history of Type II diabetes. There was no effect of family history of Type 
II diabetes on sympathetic or parasympathetic recovery following any of the stress tasks. 
Thus, my hypothesis was not supported. Previous research on autonomic recovery in 
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participants with a family history of Type II diabetes is limited. One study found an effect 
of family history on RSA reactivity, but the effect was moderated by insulin sensitivity, 
and there were no differences between groups on RSA recovery (Lindmark et al., 2003). 
The literature provides numerous examples of altered autonomic control in people with a 
family history of Type II diabetes (e.g. Carnethon et al., 2003). The small sample size in 
the family history group might have resulted in too little power to reveal an effect. 
Ethnicity and recovery. The last aim of the current study was to examine the 
effect of ethnicity on sympathetic and parasympathetic recovery following the 
psychological stress tasks. I hypothesized that participants who were black would exhibit 
an impaired recovery response following the stress tasks compared to white and Hispanic 
participants. Due to the restorative effects of parasympathetic activity, this was expected 
to be observed as RSA close to or less than baseline following the three stress tasks (i.e., 
no vagal rebound), and sympathetic activity above baseline following the math and 
speech tasks. 
In general, there was a significant effect of ethnicity on parasympathetic recovery 
following the speech task. More specifically, black participants exhibited decreased RSA 
recovery levels while white and Hispanic participants exhibited RSA levels that remained 
elevated. The hypothesis was therefore partially supported.  
Previous Research and Implications 
A genetic predisposition for cardiovascular disease, as indicated by a positive 
family history, appears to be linked to pathologic autonomic responses to acute stressors. 
Most studies have confirmed that the genetic component involved in the development of  
CVD is high. For example, the heritability of myocardial infarction has been shown to be 
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anywhere from 25-60%, atherosclerosis ~50%, and Type II diabetes anywhere between 
40-80% (Lusis, Mar, and Pajukanta, 2004). Additionally, one twin study on the genetic 
influence on resting and stress levels of SBP, DBP, HR, PEP, and RSA during a reaction 
time and mental arithmetic stressor reported the heritability of resting PEP to be 64 – 
70%, PEP during stress to be 56 – 74%, resting RSA to be ~31%, and RSA during stress 
as 44 – 54% (De Geus, Kupper, Boomsma, & Snieder, 2007). Further, genetic influences 
on autonomic and cardiovascular reactivity have been reported to be between 79 – 82% 
(Lensvett-Mulders & Hettema, 2001; McCaffery, Bleil, Pogue-Geile, Ferrell, & Manuck, 
2003).  
Similarly, the current study found significant effects of family history of 
cardiovascular disease, hypertension, related cardiovascular diseases, stroke, and 
borderline effects for family history of Type II diabetes on exaggerated autonomic 
reactivity to both active- and passive-coping stressors. A meta-analysis found that DBP 
reactivity to stress is the most consistent reactivity measure in participants with a positive 
family history of hypertension (Fredrikson & Matthews, 1990). An interesting study 
reported that in black and white children matched with either their sibling or controls, 
only black children demonstrated a significant relationship between sibling DBP 
reactivity, indicated that black children have a stronger genetic influence on 
cardiovascular reactivity (Wilson, Holmes, Arheart, & Alpert, 1995). Given these 
previous studies, it is intriguing that the effect of parental history of hypertension was 
only seen in black and Hispanic, and not white, participants. 
Genetic factors do not explain all of the variability in a person’s stress sensitivity; 
it is more likely that an inherited hyper-reactive response combined with increased 
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psychosocial stress and poor lifestyle choices can intensify the “wear-and-tear” of the 
body leading to allostatic load (McEwen, 1998). Allostatic load is the long-term effect of 
stress on the body that leads to chronic dysregulation of physiological systems, such as 
the autonomic nervous system, the hypothalamic-pituitary-axis, or the cardiovascular 
system. Allostatic load can occur through one of four situations: (1) frequent, repeated 
stressors, (2) the inability to adapt to a repeated stressor, (3) the inability to shut off the 
stress response resulting in impaired recovery, and (4) a blunted stress response that leads 
to overcompensation in another system (McEwen, 1998).  
It has been proposed that race and ethnicity be approached by 
psychophysiologists not as a proxy for biological and genetic differences, but rather as a 
proxy for the outcome of varying chronic stressors in the environment, such as racism 
and discrimination (Anderson et al., 1993). Blacks and Hispanics share many of the same 
social (e.g. discrimination, racism), environmental (e.g. greater poverty, unemployment), 
and behavioral (e.g. obesity) stressors. Using physiological variables to measure allostatic 
load “constitutes a means to access the collective impact of the many environmental and 
behavioral factors that constitute differences in socioeconomic status” (McEwen & 
Seeman, 1999). The dysregulation in autonomic reactivity due to allostatic load is one 
mechanism that would explain why group differences in parental history of hypertension 
and related cardiovascular diseases are only apparent in black and Hispanic participants. 
The reactivity patterns seen in Blacks to the cold and speech tasks are examples of the 
fourth type of allostatic load patterns: an inadequate response of the autonomic nervous 
system. It is tempting to speculate as to whether other physiological systems, such as the 
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inflammatory response, were concurrently over-activated, however this would have to be 
examined empirically.  
Ethnic differences in recovery appear to be indicative of the third type of 
allostatic load, or the inability to shut off the stress response and restore homeostasis. 
Following the speech task, black participants had parasympathetic levels that were below 
baseline whereas white and Hispanic participants exhibited parasympathetic levels that 
rebounded, or were higher than baseline. A higher parasympathetic recovery score is 
considered protective and adaptive, in that high vagal control aids in buffering the 
damaging effects caused by an increased stress response, despite any residual 
sympathetic activity. For example, one study reported that participants who had PEP and 
RSA that were higher than baseline during recovery from a mental arithmetic had lower 
levels of carotid atherosclerosis at a two-year follow up (Heponiemi et al., 2007). 
Limitations 
 Several limitations of this study warrant further discussion. One limitation is 
potential inaccuracy in classifying family history. Family history was assessed using an 
online questionnaire that was only a small part of a mass testing questionnaire packet that 
students were required to complete as a part of their registration on Sona Systems. While 
participants could hypothetically have discussed their answers with their parents or other 
relatives while they were completing the questionnaire, it is also possible that their 
responses are only best guesses as to their actual family history. Additionally, the family 
history assessment used in the current study is an imperfect measure of genetics. 
 Another limitation of the study is that ethnicity was not examined using 
subcategories that are more specific. For example, black participants identified 
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themselves as African, African American, Caribbean American, or Jamaican American. 
Hispanic participants identified themselves as Puerto Rican, Cuban, Columbian, or 
Mexican American. Some research suggests that there are reactivity differences among 
ethnic subgroups. For example, Arthur, Katkin, and Mezzacappa (2004) reported 
different heart periods variability, PEP, and cardiac output reactivity between African 
Americans and Caribbean Americans during a cold pressor task. This may be an 
important factor to consider, as the prevalence of cardiovascular disease and related 
diseases differ between ethnic subgroups. Similarly, Hispanic Americans differ in the 
degree to which they may be identified as a minority because of differences in skin tone, 
accent, and name, and therefore can differ in the degree to which they experience the 
racism and discrimination that is associated with reactivity (Salomon & Jagusztyn, 2008). 
All participants were college students; therefore, the different ethnic groups may 
be more similar to one another in terms of their socio-economic status than is seen in the 
population. Citing data obtained from the U.S. Census Bureau, Barr (2008) reported that 
Blacks in the United States are more likely than Whites to (a) never graduate from high 
school and (b) graduate from high school but not go on to college (Barr, 2008, p. 49). 
Differences in terms of socio-economic status, which is in part measured by educational 
attainment, are theorized to play important roles in cardiovascular hyper-reactivity and 
disease development (Pickering, 1999). This may affect the study’s external validity and 
difficult to generalize the results to the general population. 
 The sample size may have been too small to detect true differences in the effect of 
ethnicity and family history of stroke and diabetes on reactivity and recovery. This can be 
attributed to the conservative criteria used in classifying the family history categories. 
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Finally, a significance level of .05 was used for all a priori hypotheses and experiment-
wise Type I error rates were not controlled for. As a result, I would caution against over-
interpretation of the results until the findings have been successfully replicated. 
Future Directions 
The current study sheds some light on the combined effects of ethnicity and a 
hereditary predisposition for CVD on autonomic responses during and after a 
psychological stressor. Future studies should attempt to recruit participants from a 
community sample and take care that the sample is representative of the population in 
terms of SES and education. It would be ideal if future studies would assess family 
history through direct means, such as accessing medical records. Further examination of 
the effect of family history of diabetes is warranted, as the current study may have lacked 
enough participants in order to see a true effect. Type II diabetes is closely related to 
autonomic dysfunction, and it is hypothesized that prior to the onset of Type II diabetes, 
low vagal tone leads to a decrease in insulin secretion and an increase in the production 
of glucose, while high sympathetic activation leads to increases in circulating glucose 
(see Masi, 2007). Additionally, the current study only examined autonomic responses in 
females. Therefore, future studies should include a male sample so that gender effects 
could be examined. Finally, the current study demonstrates the importance of measuring 
both branches of the autonomic nervous system, and future studies should include 
measures of parasympathetic reactivity in addition to common sympathetic and vascular 
measures. 
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Summary and Conclusions 
Historically, research examining the relationship between cardiovascular 
reactivity and a genetic predisposition for the development of cardiovascular disease as 
indicated by a positive family history has focused on sympathetic hyper-reactivity. The 
current study found that family history groups generally differed not on sympathetic 
measures, but on parasympathetic responses. This supports the importance of exaggerated 
parasympathetic reactivity in the development of cardiovascular disease. Gianaros, 
Salomon, and colleagues (2005) reported similar findings, where greater parasympathetic 
withdrawal while preparing a speech was related to more extensive coronary and aortic 
calcification at a median of 282 days later. Interestingly, HR, SBP, and DBP were not 
significant predictors for calcification (Gianaros et al., 2005). However, opposite findings 
have also been reported. For  example, participants from a large-scale epidemiological 
study that had greater HR increases, greater RSA decreases, and greater PEP decreases to 
a mental arithmetic task had less carotid atherosclerosis two years later (Heponiemi et al., 
2007). Previous studies have found a relationship between increased sympathetic 
reactivity and risk for cardiovascular disease and hypertension in healthy (Treiber et al., 
2003) and patient populations (e.g. Barnett, Spence, Manuck, & Jennings, 1997). There is 
also an established link between lower parasympathetic influences at a resting state and 
risk for future cardiovascular disease (Liao et al., 1996) as well as mortality from 
cardiovascular disease (La Rovere, Bigger, Marcus, Mortara, & Schwartz, 1998).  
The results from the current study suggest that there are altered parasympathetic 
responses to a stressful task or event in healthy women who are at a higher risk for 
disease. Exaggerated parasympathetic responses to tasks at an early age may contribute to 
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the lowered resting parasympathetic levels seen later in life. An important finding in the 
current study is the evidence of altered autonomic responses in healthy individuals with a 
genetic predisposition for cardiovascular and related diseases, and that these differences 
can be seen before any alterations in resting levels are observed. Family history of 
hypertension may only be related to exaggerated reactivity in people with an added 
environmental risk, such as being Black or Hispanic. The current study also points to the 
importance a family history of Type II diabetes and particularly a family history of 
stroke, both of which have been largely overlooked in previous research examining 
family history and cardiovascular reactivity. 
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Appendix A: Family History Questionnaire 
Please answer the following about your biological mother: 
 
1. What is your mother’s age? __________ or □ I don’t know or □ Deceased 
2. Has your mother ever been diagnosed with or treated for the following: 
a. Hypertension or high blood pressure?  □ Yes  □ No  □ I don’t know 
b. High cholesterol?  □ Yes  □ No  □ I don’t know 
c. Type 1 or insulin-dependent diabetes?  □ Yes  □ No  □ I don’t know 
d. Type 2, late-onset, or adult-onset diabetes?  □ Yes  □ No  □ I don’t know 
e. Stroke?  □ Yes  □ No  □ I don’t know 
f. Heart attack or myocardial infarction?  □ Yes  □ No  □ I don’t know 
g. Coronary heart disease?  □ Yes  □ No  □ I don’t know 
h. Heart failure?  □ Yes  □ No  □ I don’t know 
i. Any other cardiovascular diseases?  □ Yes  □ No  □ I don’t know 
j. Depression?  □ Yes  □ No  □ I don’t know 
 
3. If you answered “yes” to question e, f, g, or h, did the event occur before age 55? 
 □ Yes  □ No □ I don’t know 
Please answer the following about your biological father: 
4. What is your father’s age? __________ or □ I don’t know or □ Deceased 
5. Has your father ever been diagnosed with or treated for the following: 
a. Hypertension or high blood pressure?  □ Yes  □ No  □ I don’t know 
b. High cholesterol?  □ Yes  □ No  □ I don’t know 
c. Type 1 or insulin-dependent diabetes?  □ Yes  □ No  □ I don’t know 
d. Type 2, late-onset, or adult-onset diabetes?  □ Yes  □ No  □ I don’t know 
e. Stroke?  □ Yes  □ No  □ I don’t know 
f. Heart attack or myocardial infarction?  □ Yes  □ No  □ I don’t know 
g. Coronary heart disease?  □ Yes  □ No  □ I don’t know 
h. Heart failure?  □ Yes  □ No  □ I don’t know 
i. Any other cardiovascular diseases?  □ Yes  □ No  □ I don’t know 
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j. Depression?  □ Yes  □ No  □ I don’t know 
 
6. If you answered “yes” to question e, f, g, or h, did the event occur before age 55? 
 □ Yes  □ No □ I don’t know 
Please answer the following about your biological paternal grandmother: 
7. What is your grandmother’s age? __________ Years or □ I don’t know or □ 
Deceased 
8. Has your grandmother ever been diagnosed with or treated for the following: 
a. Hypertension or high blood pressure?  □ Yes  □ No  □ I don’t know 
b. High cholesterol?  □ Yes  □ No  □ I don’t know 
c. Type 1 or insulin-dependent diabetes?  □ Yes  □ No  □ I don’t know 
d. Type 2, late-onset, or adult-onset diabetes?  □ Yes  □ No  □ I don’t know 
e. Stroke?  □ Yes  □ No  □ I don’t know 
f. Heart attack or myocardial infarction?  □ Yes  □ No  □ I don’t know 
g. Coronary heart disease?  □ Yes  □ No  □ I don’t know 
h. Heart failure?  □ Yes  □ No  □ I don’t know 
i. Any other cardiovascular diseases?  □ Yes  □ No  □ I don’t know 
j. Depression?  □ Yes  □ No  □ I don’t know 
 
9. If you answered “yes” to question e, f, g, or h, did the event occur before age 55? 
 □ Yes  □ No □ I don’t know 
Please answer the following about your biological paternal grandfather: 
10. What is your grandfather’s age? __________ Years or □ I don’t know or □ 
Deceased 
11. Has your grandfather ever been diagnosed with or treated for the following: 
a. Hypertension or high blood pressure?  □ Yes  □ No  □ I don’t know 
b. High cholesterol?  □ Yes  □ No  □ I don’t know 
c. Type 1 or insulin-dependent diabetes?  □ Yes  □ No  □ I don’t know 
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d. Type 2, late-onset, or adult-onset diabetes?  □ Yes  □ No  □ I don’t know 
e. Stroke?  □ Yes  □ No  □ I don’t know 
f. Heart attack or myocardial infarction?  □ Yes  □ No  □ I don’t know 
g. Coronary heart disease?  □ Yes  □ No  □ I don’t know 
h. Heart failure?  □ Yes  □ No  □ I don’t know 
i. Any other cardiovascular diseases?  □ Yes  □ No  □ I don’t know 
j. Depression?  □ Yes  □ No  □ I don’t know 
 
12. If you answered “yes” to question e, f, g, or h, did the event occur before age 55? 
 □ Yes  □ No □ I don’t know 
Please answer the following about your biological maternal grandmother: 
13. What is your grandmother’s age? __________ Years or □ I don’t know or □ 
Deceased 
14. Has your grandmother ever been diagnosed with or treated for the following: 
a. Hypertension or high blood pressure?  □ Yes  □ No  □ I don’t know 
b. High cholesterol?  □ Yes  □ No  □ I don’t know 
c. Type 1 or insulin-dependent diabetes?  □ Yes  □ No  □ I don’t know 
d. Type 2, late-onset, or adult-onset diabetes?  □ Yes  □ No  □ I don’t know 
e. Stroke?  □ Yes  □ No  □ I don’t know 
f. Heart attack or myocardial infarction?  □ Yes  □ No  □ I don’t know 
g. Coronary heart disease?  □ Yes  □ No  □ I don’t know 
h. Heart failure?  □ Yes  □ No  □ I don’t know 
i. Any other cardiovascular diseases?  □ Yes  □ No  □ I don’t know 
j. Depression?  □ Yes  □ No  □ I don’t know 
 
15. If you answered “yes” to question e, f, g, or h, did the event occur before age 55? 
 □ Yes  □ No □ I don’t know 
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Please answer the following about your biological maternal grandfather: 
16. What is your grandfather’s age? __________ Years or □ I don’t know or □ 
Deceased 
17. Has your grandfather ever been diagnosed with or treated for the following: 
a. Hypertension or high blood pressure?  □ Yes  □ No  □ I don’t know 
b. High cholesterol?  □ Yes  □ No  □ I don’t know 
c. Type 1 or insulin-dependent diabetes?  □ Yes  □ No  □ I don’t know 
d. Type 2, late-onset, or adult-onset diabetes?  □ Yes  □ No  □ I don’t know 
e. Stroke?  □ Yes  □ No  □ I don’t know 
f. Heart attack or myocardial infarction?  □ Yes  □ No  □ I don’t know 
g. Coronary heart disease?  □ Yes  □ No  □ I don’t know 
h. Heart failure?  □ Yes  □ No  □ I don’t know 
i. Any other cardiovascular diseases?  □ Yes  □ No  □ I don’t know 
j. Depression?  □ Yes  □ No  □ I don’t know 
 
18. If you answered “yes” to question e, f, g, or h, did the event occur before age 55? 
 □ Yes  □ No □ I don’t know 
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1. Age:   ____ 
2. When was the first day of menstruation during your last cycle (mm/dd/yyyy)? ______ 
3. Have you ever been diagnosed with any of the following conditions: 
⁪ Heart disease   ⁪ Hypertension (high blood pressure) ⁪ Stroke 
⁪ High cholesterol  ⁪ Arrhythmia (irregular heartbeat)  ⁪ Diabetes 
⁪ Heart valve problems 
4. Please list all prescription and non-prescription medications that you are currently 
taking.  Be sure to also include any medications you have taken in the last 48 hours, 
even if it is something you do not regularly take (such as aspirin or cold medicine). 
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________ 
5. When did you last eat? _____________ am / pm (circle one) 
 a. What did you eat?  __________________________________________________ 
6. Do you drink beverages containing caffeine?  ⁪Yes ⁪No  (check one) 
 If yes, when did you last drink a caffeinated beverage?  
  Time: _______ am/pm (circle one) 
How many caffeinated drinks have you had today?  ___________ 
How many servings (8 oz.) of “energy drinks” (e.g., Redbull, Rockstar, etc.) do 
you consume in a typical day?  
 Regular: ____________ Diet: _____________ 
 How many servings (8 oz.) of soda do you consume in a typical day?  
 Regular: ____________ Diet: _____________ 
7. Do you smoke nicotine cigarettes? ⁪Yes ⁪ No (check one) 
 If yes, when did you last smoke? Time: ___________ am / pm (circle one) 
 How many nicotine cigarettes have you smoked today?  ___________ 
 How many nicotine cigarettes do you normally smoke in a day? ___________ 
8. Do any of the following describe your typical diet?   □ Omnivore (Meat, etc.) 
□ Vegetarian  □ Vegan   □ Pescetarian  □ Other: _________________ 
9. When did you last exercise? Please consider any activity that elevated your heart rate 
for 30 or more minutes.  
  Date: __________ Time: ____________    Activity: ____________  
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Table C1  
Mean RSA, PEP, and HR Reactivity and Recovery Scores 
    95% CI    
  M SE LL UL t df p 
Reactivity         
Prep         
 RSA -0.240 0.073 -0.384 -0.095 -3.286 134 0.001 
  PEP -13.404 1.095 -15.571 -11.238 -12.240 129 <0.001 
  HR 9.342 0.773 7.812 10.871 12.078 134 <0.001 
Speech         
 RSA -0.367 0.093 -0.551 -0.182 -3.932 134 <0.001 
  PEP -19.428 1.219 -21.840 -17.017 -15.942 128 <0.001 
  HR 14.622 0.908 12.827 16.418 16.106 134 <0.001 
Math         
 RSA -0.080 0.078 -0.235 0.074 -1.028 133 0.306 
  PEP -10.049 0.874 -11.779 -8.319 -11.493 129 <0.001 
  HR 8.050 0.667 6.730 9.370 12.062 133 <0.001 
Cold         
 RSA 0.443 0.055 0.333 0.553 7.986 134 <0.001 
  PEP -2.590 0.599 -3.776 -1.404 -4.321 129 <0.001 
  HR -1.866 0.384 -2.625 -1.106 -4.857 134 <0.001 
Recovery         
Speech         
 RSA 0.106 0.043 0.020 0.191 2.451 133 0.016 
  PEP -5.947 0.584 -7.103 -4.792 -10.184 129 <0.001 
  HR 0.304 0.328 -0.346 0.953 0.925 133 0.357 
Math         
 RSA 0.127 0.044 0.039 0.214 2.849 133 0.005 
  PEP -3.102 0.455 -4.002 -2.201 -6.815 129 <0.001 
  HR -0.289 0.328 -0.939 0.360 -0.881 133 0.380 
Cold         
 RSA 0.166 0.042 0.083 0.249 3.964 134 <0.001 
  PEP -3.353 0.520 -4.381 -2.325 -6.453 130 <0.001 
  HR -1.288 0.320 -1.921 -0.656 -4.028 134 <0.001 
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Table D1 
Hypothesis 1: Parent HT. Means, standard deviations, and significance testing 
 
FH + FH - 
    
 
M SE 95% CI M SE 95% CI df F p η2 
RSA 
     
 
         Math -0.083 0.106 [-0.292, 0.127] -0.118 0.123 [-0.361, 0.126] 1, 101 0.046 0.830 0 
     Cold 0.540 0.072 [0.397, 0.683] 0.280 0.084 [0.112, 0.447] 1, 102 5.411 0.022 0.050 
     Prep -0.209 0.102 [-0.412, -0.006] -0.304 0.119 [-0.540, -0.067] 1, 101 0.362 0.549 0.004 
     Speech -0.324 0.120 [-0.563, -0.086] -0.518 0.140 [-0.796, -0.241] 1, 101 1.100 0.297 0.011 
PEP 
          
     Math -10.26 1.21 [-12.67, -7.86] -8.04 1.40 [-10.82, -5.26] 1, 100 1.436 0.234 0.014 
     Cold -3.01 0.87 [-4.73, -1.29] -2.05 1.02 [-4.07, -0.03] 1, 100 0.516 0.474 0.005 
     Prep -13.46 1.54 [-16.51, -10.42] -12.70 1.81 [-16.29, -9.11] 1, 100 0.103 0.749 0.001 
     Speech -18.24 1.81 [-21.84, -14.65] -19.44 2.07 [-23.56, -15.33] 1, 99 0.190 0.664 0.002 
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Table D2 
Hypothesis 1: Parent Any. Means, standard deviations, and significance testing 
 
FH + FH - 
    
 
M SE 95% CI M SE 95% CI df F p η2 
RSA 
               Math -0.059 0.092 [-0.241, 0.124] -0.185 0.150 [-0.482, 0.113] 1, 109 0.505 0.479 0.005 
     Cold 0.512 0.061 [0.392, 0.632] 0.210 0.099 [0.013, 0.407] 1, 110 6.723 0.011 0.058 
     Prep -0.192 0.087 [-0.364, -0.020] -0.451 0.141 [-0.730, -0.172] 1, 109 2.434 0.122 0.022 
     Speech -0.305 0.102 [-0.507, -0.103] -0.608 0.166 [-0.936, -0.279] 1, 109 2.407 0.124 0.022 
PEP 
          
     Math -10.62 1.15 [-12.90, -8.33] -8.10 1.88 [-11.82, -4.39] 1, 108 1.304 0.256 0.012 
     Cold -2.41 0.76 [-3.91, -0.91] -2.99 1.26 [-5.49, -0.49] 1, 108 0.153 0.696 0.001 
     Prep -13.04 1.36 [-15.74, -10.33] -13.86 2.27 [-18.36, -9.36] 1, 108 0.096 0.757 0.001 
     Speech -19.18 1.61 [-22.37, -16.00] -19.47 2.60 [-24.63, -14.32] 1, 107 0.009 0.925 0 
 
  
112 
Appendix D (Continued) 
Table D3 
Hypothesis 1: Family CVD. Means, standard deviations, and significance testing 
 
FH + FH - 
    
 
M SE 95% CI M SE 95% CI df F p η2 
RSA 
          
     Math -0.115 0.119 [-0.353, 0.123] 0.081 0.211 [-0.340, 0.502] 1, 68 0.626 0.432 0.009 
     Cold 0.397 0.075 [0.246, 0.547] 0.650 0.133 [0.385, 0.915] 1, 69 2.695 0.105 0.038 
     Prep -0.135 0.100 [-0.333, 0.064] -0.320 0.176 [-0.671, 0.032] 1, 69 0.806 0.373 0.012 
     Speech -0.327 0.118 [-0.561, -0.092] -0.069 0.207 [-0.482, 0.344] 1, 69 1.147 0.288 0.016 
PEP 
          
     Math -10.51 1.53 [-13.56, -7.47] -10.28 2.58 [-15.43, -5.14] 1, 67 0.006 0.940 0 
     Cold -2.12 0.93 [-3.97, -0.27] -3.17 1.62 [-6.40, 0.07] 1, 67 0.310 0.579 0.005 
     Prep -13.04 1.55 [-16.13, -9.94] -13.79 2.71 [-19.20, -8.38] 1, 67 0.057 0.812 0.001 
     Speech -19.86 1.85 [-23.55, -16.18] -18.72 3.15 [-25.01, -12.44] 1, 68 0.096 0.758 0.001 
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Table D4 
Hypothesis 1: Family Stroke. Means, standard deviations, and significance testing  
 
FH + FH - 
    
 
M SE 95% CI M SE 95% CI df F p η2 
RSA 
          
     Math -0.201 0.139 [-0.479, 0.076] -0.075 0.169 [-0.413, 0.262] 1, 64 0.313 0.578 0.005 
     Cold 0.327 0.094 [0.139, 0.514] 0.508 0.114 [0.280, 0.735] 1, 64 1.426 0.237 0.022 
     Prep -0.301 0.117 [-0.535, -0.066] -0.193 0.143 [-0.479, 0.092] 1, 64 0.320 0.573 0.005 
     Speech -0.677 0.129 [-0.936, -0.418] -0.033 0.157 [-0.347, 0.282] 1, 64 9.502 0.003 0.129 
PEP 
          
     Math -11.43 1.86 [-15.13, -7.72] -10.37 2.26 [-14.89, -5.84] 1, 64 0.126 0.724 0.002 
     Cold -2.46 1.01 [-4.47, -0.45] -0.18 1.25 [-2.68, 2.33] 1, 63 1.950 0.168 0.030 
     Prep -14.44 1.72 [-17.88, -11.00] -10.60 2.14 [-14.87, -6.32] 1, 63 1.882 0.175 0.029 
     Speech -22.42 2.22 [-26.85, -17.98] -14.15 2.68 [-19.50, -8.81] 1, 63 5.405 0.023 0.079 
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Table D5 
Hypothesis 1: Family Diabetes. Means, standard deviations, and significance testing 
 
FH + FH - 
    
 
M SE 95% CI M SE 95% CI df F p η2 
RSA 
          
     Math -0.363 0.155 [-0.673, -0.052] 0.127 0.192 [-0.259, 0.512] 1, 52 3.433 0.070 0.062 
     Cold 0.369 0.106 [0.156, 0.582] 0.510 0.131 [0.246, 0.774] 1, 52 0.618 0.436 0.012 
     Prep -0.433 0.131 [-0.706, -0.181] -0.015 0.162 [-0.340, 0.310] 1, 52 3.758 0.058 0.067 
     Speech -0.603 0.159 [-0.921, -0.285] -0.101 0.196 [-0.495, 0.293] 1, 52 3.511 0.067 0.067 
PEP 
          
     Math -12.46 2.14 [-16.75, -8.16] -8.07 2.54 [-13.16, -2.97] 1, 52 1.627 0.208 0.030 
     Cold -3.05 1.10 [-5.27, -0.84] -0.02 1.29 [-2.61, 2.57] 1, 51 2.934 0.093 0.054 
     Prep -16.67 2.23 [-21.15, -12.19] -10.21 2.61 [-15.46, -4.97] 1, 51 3.235 0.078 0.060 
     Speech -23.58 2.66 [-28.92, -18.24] -15.51 3.16 [-21.85, -9.17] 1, 52 3.547 0.065 0.064 
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Table D6 
Hypothesis 5a: Race x Parent HT. Means, standard deviations, and significance testing 
 
White Black Hispanic 
    
 
FH+ FH- FH+ FH- FH+ FH- 
    
 
M SE M SE M SE M SE M SE M SE df F p η2 
RSA 
    
        
    
     Math -0.264 0.188 -0.038 0.200 -0.066 0.190 -0.366 0.227 0.057 0.179 0.019 0.225 2, 98 0.800 0.452 0.016 
     Cold 0.460 0.128 0.513 0.134 0.434 0.123 0.004 0.155 0.723 0.120 0.242 0.152 2, 99 2.473 0.090 0.048 
     Prep -0.294 0.182 -0.203 0.193 -0.351 0.183 -0.369 0.220 0.002 0.173 -0.374 0.219 2, 98 0.797 0.453 0.016 
     Speech -0.303 0.216 -0.468 0.229 -0.447 0.216 -0.574 0.261 -0.221 0.206 -0.531 0.258 2, 98 0.090 0.914 0.002 
PEP 
    
        
    
     Math -8.72 2.22 -10.90 2.30 -10.63 2.11 -5.88 2.55 -11.19 2.00 -6.71 2.52 2, 97 1.480 0.233 0.030 
     Cold -2.06 1.62 -1.28 1.67 -3.15 1.50 -2.81 1.85 -3.66 1.46 -2.24 1.90 2, 97 0.053 0.948 0.001 
     Prep -8.95 2.83 -12.71 2.92 -14.58 2.62 -10.90 3.25 -16.16 2.55 -14.51 3.33 2, 97 0.871 0.422 0.018 
     Speech -14.43 3.40 -21.54 3.40 -19.34 3.14 -15.34 3.78 -20.26 2.97 -20.90 3.74 2, 96 1.317 0.273 0.027 
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Table D7 
Hypothesis 5a: Race x Parent Any. Means, standard deviations, and significance testing 
 
White Black Hispanic 
    
 
FH+ FH- FH+ FH- FH+ FH- 
    
 
M SE M SE M SE M SE M SE M SE df F p η2 
RSA 
    
        
    
     Math -0.227 0.162 -0.198 0.247 -0.058 0.170 -0.431 0.284 0.095 0.156 0.039 0.259 2, 106 0.440 0.645 0.008 
     Cold 0.488 0.106 0.525 0.162 0.360 0.107 -0.132 0.188 0.672 0.102 0.147 0.169 2, 107 2.600 0.079 0.046 
     Prep -0.178 0.153 -0.426 0.234 -0.301 0.160 -0.455 0.270 -0.110 0.148 -0.475 0.247 2, 106 0.125 0.883 0.002 
     Speech -0.378 0.180 -0.554 0.273 -0.422 0.187 -0.630 0.318 -0.134 0.174 -0.651 0.288 2, 106 0.311 0.733 0.006 
PEP 
    
        
    
     Math -10.40 2.07 -10.57 3.18 -8.97 2.09 -7.23 3.54 -12.24 1.93 -6.35 3.21 2, 105 0.673 0.512 0.013 
     Cold -1.74 1.37 -1.31 2.10 -2.27 1.36 -4.67 2.34 -3.12 1.28 -3.30 2.22 2, 105 0.317 0.729 0.006 
     Prep -9.25 2.44 -14.48 3.75 -13.22 2.42 -11.77 4.18 -16.15 2.28 -15.05 3.96 2, 105 0.687 0.505 0.013 
     Speech -17.97 2.94 -20.58 4.43 -17.35 2.92 -17.20 4.93 -21.76 2.69 -20.28 4.47 2, 104 0.157 0.855 0.003 
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Table D8 
Hypothesis 5a: Race x Family CVD. Means, standard deviations, and significance testing 
 
White Black Hispanic 
    
 
FH+ FH- FH+ FH- FH+ FH- 
    
 
M SE M SE M SE M SE M SE M SE df F p η2 
RSA 
    
        
    
     Math -0.313 0.177 0.112 0.319 -0.184 0.242 -0.037 0.422 0.259 0.228 0.161 0.365 2, 65 0.445 0.643 0.014 
     Cold 0.349 0.114 0.870 0.204 0.322 0.149 0.309 0.262 0.540 0.150 0.653 0.234 2, 66 1.221 0.301 0.036 
     Prep -0.200 0.152 -0.215 0.276 -0.315 0.201 -0.639 0.352 0.127 0.196 -0.160 0.313 2, 66 0.251 0.779 0.008 
     Speech -0.472 0.177 0.302 0.313 -0.403 0.232 -0.563 0.411 -0.032 0.225 -0.118 0.363 2, 66 1.806 0.172 0.052 
PEP 
    
        
    
     Math -11.17 2.29 -10.73 3.97 -8.12 3.14 -13.85 5.52 -11.52 2.84 -6.60 4.59 2, 64 0.884 0.418 0.027 
     Cold -0.60 1.40 -4.49 2.41 -4.85 1.83 -3.16 3.14 -1.95 1.73 -1.23 3.05 2, 64 0.954 0.391 0.029 
     Prep -9.92 2.33 -14.09 4.02 -17.49 3.05 -16.77 5.23 -13.72 2.88 -10.64 5.08 2, 64 0.526 0.594 0.016 
     Speech -19.46 2.83 -18.51 4.89 -21.11 3.72 -23.60 6.37 -19.41 3.51 -14.84 5.66 2, 65 0.257 0.774 0.008 
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Table D9 
Hypothesis 5a: Race x Family Stroke. Means, standard deviations, and significance testing 
 
White Black Hispanic 
    
 
FH+ FH- FH+ FH- FH+ FH- 
    
 
M SE M SE M SE M SE M SE M SE df F p η2 
RSA 
    
        
    
     Math -0.207 0.248 -0.386 0.239 -0.216 0.212 0.150 0.381 -0.204 0.280 0.299 0.294 2, 61 1.000 0.374 0.032 
     Cold 0.249 0.177 0.598 0.164 0.353 0.148 0.184 0.261 0.347 0.190 0.617 0.202 2, 61  1.009 0.370 0.032 
     Prep -0.366 0.214 -0.292 0.207 -0.286 0.184 -0.159 0.330 -0.265 0.242 -0.043 0.255 2, 61 0.054 0.948 0.002 
     Speech -0.635 0.236 -0.234 0.226 -0.657 0.202 0.129 0.361 -0.764 0.262 0.177 0.278 2, 61 0.652 0.525 0.021 
PEP 
    
        
    
     Math -11.18 3.42 -14.96 3.24 -10.46 2.78 -3.80 4.99 -12.98 3.64 -8.46 3.89 2, 61 1.247 0.295 0.039 
     Cold -1.16 1.91 0.17 1.81 -4.40 1.55 -2.24 2.78 -1.28 2.03 1.62 2.30 2, 60 0.079 0.925 0.003 
     Prep -12.58 3.25 -12.44 3.08 -13.85 2.64 -7.87 4.73 -17.04 3.46 -10.17 3.91 2, 60 0.611 0.546 0.020 
     Speech -24.38 4.18 -20.57 3.76 -16.97 3.24 -5.56 5.81 -28.08 4.24 -12.19 4.53 2, 60 1.121 0.333 0.036 
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Table D10 
Hypothesis 5a: Race x Family Diabetes. Means, standard deviations, and significance testing 
 
White Black Hispanic 
    
 
FH+ FH- FH+ FH- FH+ FH- 
    
 
M SE M SE M SE M SE M SE M SE df F p η2 
RSA 
    
        
    
     Math -0.405 0.269 -0.138 0.277 -0.347 0.234 0.319 0.442 -0.303 0.297 0.389 0.310 2, 49 0.360 0.700 0.014 
     Cold 0.412 0.184 0.604 0.185 0.342 0.163 -0.107 0.297 0.286 0.200 0.763 0.209 2, 49 2.189 0.123 0.082 
     Prep -0.328 0.225 -0.219 0.233 -0.391 0.198 -0.081 0.371 -0.635 0.251 0.282 0.263 2, 49 1.475 0.239 0.057 
     Speech -0.446 0.284 -0.079 0.289 -0.708 0.247 -0.140 0.472 -0.649 0.311 -0.080 0.327 2, 49 0.078 0.925 0.003 
PEP 
    
        
    
     Math -10.92 3.99 -12.46 3.55 -11.54 3.18 -3.33 5.91 -14.90 4.02 -4.54 4.23 2, 49 1.339 0.271 0.052 
     Cold -1.29 2.04 0.92 1.83 -4.32 1.63 -2.40 3.03 -3.48 2.20 0.58 2.17 2, 48 0.139 0.871 0.006 
     Prep -11.03 4.07 -11.72 3.64 -17.05 3.24 -7.03 6.03 -21.72 4.39 -10.12 4.33 2, 48 1.396 0.257 0.055 
     Speech -18.45 4.91 -20.52 4.38 -22.28 3.92 -7.84 7.29 -29.47 4.95 -13.41 5.22 2, 49 2.177 0.124 0.082 
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Table D11  
Hypothesis 5b: Race x Parent HT. Means, standard deviations, and significance testing 
 
White Black Hispanic 
    
 
FH+ FH- FH+ FH- FH+ FH- 
    
 
M SE M SE M SE M SE M SE M SE df F p η2 
RSA 
    
        
    
     Math 0.097 0.102 0.250 0.107 0.018 0.101 0.051 0.123 0.123 0.096 0.130 0.121 2, 97 0.272 0.762 0.006 
     Cold 0.061 0.091 0.241 0.097 0.254 0.089 0.226 0.115 0.077 0.088 0.164 0.109 2, 98 0.569 0.568 0.011 
     Speech 0.065 0.092 0.299 0.100 -0.015 0.092 -0.154 0.116 0.169 0.088 0.055 0.110 2, 95 2.270 0.109 0.046 
PEP 
    
        
    
     Math -1.45 1.01 -3.93 1.04 -3.11 0.96 -3.20 1.17 -3.60 0.91 -3.73 1.15 2, 96 0.854 0.429 0.017 
     Cold -2.33 1.00 -3.27 1.04 -3.73 0.93 -4.22 1.15 -4.00 0.91 -4.21 1.18 2, 96 0.064 0.938 0.001 
     Speech -5.36 1.18 -5.99 1.18 -6.20 1.08 -6.36 1.36 -7.28 1.02 -5.33 1.29 2, 94 0.686 0.506 0.014 
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Table D12  
Hypothesis 5b: Race x Parent Any. Means, standard deviations, and significance testing 
 
White Black Hispanic 
    
 
FH+ FH- FH+ FH- FH+ FH- 
    
 
M SE M SE M SE M SE M SE M SE df F p η2 
RSA 
    
        
    
     Math 0.158 0.085 0.231 0.130 0.085 0.089 -0.040 0.149 0.141 0.082 0.062 0.135 2, 105 0.420 0.658 0.008 
     Cold 0.122 0.076 0.229 0.116 0.244 0.078 0.285 0.139 0.087 0.075 0.217 0.123 2, 106 0.094 0.910 0.002 
     Speech 0.134 0.080 0.295 0.120 -0.034 0.082 -0.141 0.148 0.192 0.077 0.044 0.127 2, 103 1.308 0.275 0.025 
PEP 
    
        
    
     Math -1.89 0.85 -4.67 1.31 -3.08 0.86 -3.85 1.46 -3.32 0.80 -4.08 1.33 2, 104 0.549 0.579 0.010 
     Cold -2.15 0.81 -4.31 1.24 -3.91 0.80 -3.43 1.39 -3.92 0.75 -4.06 1.31 2, 104 0.835 0.437 0.016 
     Speech -5.29 0.98 -6.65 1.48 -6.16 0.98 -7.15 1.75 -6.89 0.90 -5.70 1.49 2, 102 0.598 0.552 0.012 
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Table D13  
Hypothesis 5b: Race x Family CVD. Means, standard deviations, and significance testing 
 
White Black Hispanic 
    
 
FH+ FH- FH+ FH- FH+ FH- 
    
 
M SE M SE M SE M SE M SE M SE df F p η2 
RSA 
    
        
    
     Math 0.154 0.085 0.332 0.154 0.211 0.115 0.138 0.196 0.213 0.110 -0.118 0.173 2, 64 1.856 0.165 0.055 
     Cold 0.132 0.076 0.118 0.140 0.312 0.100 0.471 0.175 0.183 0.099 0.016 0.158 2, 65 0.717 0.492 0.022 
     Speech 0.101 0.090 0.448 0.159 -0.091 0.115 0.039 0.204 0.249 0.115 -0.175 0.181 2, 64 3.738 0.029 0.105 
PEP 
    
        
    
     Math -2.09 0.92 -6.1 1.59 -3.52 1.26 -1.67 2.07 -3.65 1.14 -3.35 1.85 2, 63 2.211 0.118 0.066 
     Cold -2.05 0.91 -3.94 1.56 -4.89 1.20 -2.11 2.02 -2.92 1.11 -4.16 1.96 2, 63 1.356 0.265 0.041 
     Speech -5.06 1.02 -8.08 1.77 -6.36 1.35 -6.11 2.31 -7.26 1.27 -5.94 2.06 2, 64 1.077 0.347 0.033 
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Table D14 
Hypothesis 5b: Race x Family Stroke. Means, standard deviations, and significance testing 
 
White Black Hispanic 
    
 
FH+ FH- FH+ FH- FH+ FH- 
    
 
M SE M SE M SE M SE M SE M SE df F p η2 
RSA 
    
        
    
     Math 0.198 0.115 0.274 0.112 0.226 0.099 -0.380 0.177 0.143 0.129 0.022 0.139 2, 60 3.610 0.033 0.107 
     Cold 0.152 0.106 0.104 0.102 0.214 0.092 0.334 0.160 0.105 0.116 0.109 0.124 2, 60 0.258 0.774 0.009 
     Speech 0.191 0.133 0.326 0.120 0.108 0.107 -0.326 0.216 0.248 0.141 -0.043 0.152 2, 58 2.197 0.120 0.070 
PEP 
    
        
    
     Math -2.95 1.36 -3.53 1.30 -3.38 1.10 -3.61 2.01 -2.98 1.45 -2.29 1.55 2, 60 0.104 0.902 0.003 
     Cold -2.62 1.20 -3.83 1.15 -2.77 1.00 -6.65 1.75 -1.91 1.28 -2.85 1.47 2, 59 0.715 0.494 0.024 
     Speech -6.32 1.43 -6.24 1.27 -5.37 1.10 -8.94 2.24 -5.26 1.48 -5.13 1.56 2, 58 0.879 0.421 0.029 
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Table D15  
Hypothesis 5b: Race x Family Diabetes. Means, standard deviations, and significance testing 
 
White Black Hispanic 
    
 
FH+ FH- FH+ FH- FH+ FH- 
    
 
M SE M SE M SE M SE M SE M SE df F p η2 
RSA 
    
        
    
     Math 0.107 0.156 0.220 0.160 0.079 0.137 -0.176 0.257 0.058 0.172 -0.067 0.185 2, 48 0.598 0.554 0.024 
     Cold 0.185 0.120 0.050 0.125 0.069 0.107 0.414 0.200 -0.063 0.134 0.080 0.143 2, 48 1.592 0.214 0.062 
     Speech 0.060 0.140 0.232 0.149 -0.114 0.123 -0.396 0.229 0.108 0.155 -0.074 0.162 2, 47 1.208 0.308 0.049 
PEP 
    
        
    
     Math -2.33 1.47 -3.97 1.31 -4.00 1.17 -4.79 2.21 -2.65 1.50 -3.30 1.59 2, 48 0.067 0.935 0.003 
     Cold -4.38 1.35 -3.14 1.23 -4.21 1.10 -5.31 2.00 -5.04 1.46 -2.69 1.45 2, 47 0.651 0.526 0.027 
     Speech -7.40 1.46 -6.07 1.30 -6.48 1.17 -10.11 2.22 -7.32 1.52 -6.09 1.57 2, 48 1.459 0.242 0.057 
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